Genetic Inhibition of the Ubiquitin-Proteasome Pathway: Insights Into Proteasomal Targeting by Ghaboosi, Nazli
GENETIC INHIBITION OF THE UBIQUITIN-PROTEASOME 
PATHWAY:  INSIGHTS INTO PROTEASOMAL TARGETING 
 
 
 
Thesis by 
Nazli Ghaboosi 
 
 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
CALIFORNIA INSTITUTE OF TECHNOLOGY 
Pasadena, California 
2007 
(Defended April 4, 2007)
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2007 
Nazli Ghaboosi 
All Rights Reserved
 iii 
ACKNOWLEDGEMENTS 
I would like to thank my adviser, Ray Deshaies, whose admirable expertise and devotion 
to research taught me how to think about science.  Thank you to the Howard Hughes 
Medical Institute for funding my graduate work.  My gratitude also goes to my colleagues 
in the Deshaies laboratory, particularly Rati Verma and Rob Oania for their patience in 
teaching me the details of yeast biology, especially the remarkable skill required to purify 
proteasome complexes from cells.   
 
Thanks to my committee members Paul Sternberg, Bruce Hay, and Alex Varshavsky for 
their support throughout the years.  When I first started this project, I turned to Alex 
Varshavsky for advice, as his own examination of an E1 mutant provided scientific 
breakthroughs that created an entire field of research.  That initial conversation gave me 
invaluable insights into the problem I was tackling and more motivation than he knows.  
Over the years, I looked over my notes from that day more than once.  Thank you to 
Bruce Hay and Paul Sternberg for personally taking the time to train me during my first 
clueless year of graduate school.  Their passion for teaching is clear in their devotion to 
explaining complex genetics to someone who had never even seen Drosophila or C. 
elegans before.   
 
Thanks to my wonderful, brilliant friends at Caltech, especially the ladies of girls’ lunch; 
they made my time here enjoyable and allowed me to keep my sanity through all those 
late nights in lab.       
 
I am deeply grateful to my family for their unwavering support and unconditional love.  
Thanks to my fiancé Fahim, who appeared in my life during the last year of my PhD when I 
was most in need of motivation.  His passion for mathematics reignited my own intellectual 
curiosity at the most crucial time in my education.  He gave me the courage to complete 
my final experiments with pleasure.  I appreciate all of the love and support I received from 
him and his family as I undertook the arduous task of completing years of research.    
 
My deep gratitude goes to my brother Reza, who was my roommate throughout most of 
the adventure of graduate school, and whose countless hours of reading law books made 
reading genetics papers seem fun in comparison.  I could not have survived graduate 
school (or life) without his constant support and friendship.  I would also like to especially 
thank my father Majid, whose passion for knowledge inspired me throughout my life, and 
who taught me everything I know, from literature to film to calculus. 
 
Most of all, this thesis is dedicated to my mother, Nadereh Ansari.  Her support, 
encouragement, and love have sustained me throughout my life.  She cared so deeply for 
my education at every step, for which I am truly appreciative.  Through her strength, 
wisdom, and grace, she has provided me with a model of how to be a successful scientist, 
and a successful human being.  She is the inspiration behind the research involved in this 
thesis and behind everything that I achieve in life.  
  
iv 
ABSTRACT 
Regulated proteolysis plays a major role in diverse cellular processes, including 
cell-cycle progression, endocytosis, apoptosis, transcription, and signal transduction.  
Proteins destined for proteolysis undergo two key steps in the ubiquitin-proteasome 
pathway.  First, a complex enzymatic cascade controls conjugation of a multiubiquitin 
chain onto a protein.  Once ubiquitinated, protein substrates must be recognized and 
targeted to the proteasome complex, where they are unfolded and degraded.  Receptor 
proteins, such as Rad23, recognize ubiquitinated proteins and deliver them to the 
proteasome. 
While the list of enzymes involved in ubiquitination is steadily growing, the first 
enzymatic reaction required for all ubiquitin-dependent processes is catalyzed by one 
protein, the ubiquitin-activating enzyme, E1.  In this work, we describe a genetic screen 
that targets the Saccharomyces cerevisiae E1 gene, UBA1.  We report the isolation of 
uba1-204, a temperature-sensitive allele UBA1 that exhibits dramatic inhibition of the 
ubiquitin-proteasome pathway.  Shifting mutant cells to the restrictive temperature results 
in the depletion of cellular ubiquitin conjugates within minutes, accompanied by 
stabilization of multiple protein substrates.  We have employed the tight phenotype of this 
mutant to investigate the role ubiquitin conjugates play the recognition and delivery of 
substrates to the proteasome. 
It is possible to purify intact and active proteasomes complexes from uba1-204 
cells.  In the absence of ubiquitin activation, these proteasome complexes are depleted of 
ubiquitin conjugates and the ubiquitin-binding receptor proteins Rad23 and Dsk2.  Binding 
of Rad23 to these proteasomes in vitro is enhanced by addition of either free or substrate-
linked ubiquitin chains.  Moreover, association of Rad23 with proteasomes in mutant and 
wild-type cells is improved upon stabilizing ubiquitin conjugates with proteasome inhibitor.  
We propose that recognition of polyubiquitin chains by Rad23 promotes its shuttling to the 
proteasome in vivo.  As an additional example of the value of this novel genetic mutant in 
the study of the ubiquitin-proteasome system, we present preliminary results from a 
quantitative mass spectrometric analysis of the proteins associated with proteasome 
complexes isolated from uba1-204 cells.  
In summary, we have created a genetic method of rapidly inhibiting the ubiquitin-
proteasome system.  This will enable future exploration of the ubiquitin-proteasome 
system and potentially many other ubiquitin-dependent cellular processes.   
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C h a p t e r  1  
BACKGROUND 
 
THE DISCOVERY OF UBIQUITIN 
Ubiquitin, a small 76 residue protein named for its ubiquitous presence (“probably 
represented universally in all living cells”), was first identified by Goldstein et al. in 1975.  
While its function remained a mystery, it was found to be part of a branched protein 
covalently linked to histone 2A (Goldknopf and Busch 1977).  In 1980, ubiquitin was 
purified and found to ligate onto proteins in an ATP-dependent manner, and it was 
proposed that this ligation marked proteins for proteolysis (Hershko et al. 1980).   
The discovery of ubiquitin and its conjugation onto proteins lead to dissection of the 
complex enzymatic cascade involved in regulating the ubiquitination process.  The first 
reaction required for all ubiquitin-dependent cellular functions is the activation of ubiquitin 
by ubiquitin-activating enzyme, or E1 (Ciechanover et al. 1981).  E1 activates ubiquitin by 
catalyzing a two-step process.  First, the E1 enzyme forms a ubiquitin-adenylate 
intermediate in an ATP-dependent reaction.  Ubiquitin is then transferred to an active-site 
cysteine residue of E1 to form a covalent thioester bond (Ciechanover et al. 1981).  E1 can 
then transfer the activated ubiquitin moiety to a cysteine residue on a ubiquitin conjugating 
enzyme (E2) (Hershko et al. 1983; Pickart and Rose, 1985), and thereafter to a substrate 
with the help of a ubiquitin ligase protein (E3) (Hershko et al. 1983).  A full historical 
account of early biochemical discoveries in the ubiquitin-proteasome system can be found 
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in Finley, Ciechanover, and Varshavsky (2004), Hershko et al. (2000), and Ciechanover 
(2005). 
A major genetic breakthrough came in 1984, when Varshavsky and colleagues 
characterized a temperature-sensitive mouse cell line with a defect in proteolysis and 
showed for the first time that ubiquitin conjugation and protein degradation are linked in 
vivo (Ciechanover et al. 1984; Finley et al. 1984).  This cell line (ts85) was shown to carry 
a conditional allele of the ubiquitin-activating enzyme, E1.  This work demonstrated that 
ubiquitin conjugation is required for proteolysis, cell viability, cell-cycle progression, and 
stress response, revealing the scope of ubiquitination in mammalian cells.     
Further work went on to define the first degradation signals and identify some of 
the enzymes involved in the pathway.  It is now appreciated that regulated proteolysis is 
responsible for controlling a broad array of cellular processes, including cell-cycle 
progression, endocytosis, apoptosis, transcription, antigen presentation, signal 
transduction, and protein quality control.  The significance of the ubiquitin-proteasome 
system was acknowledged in 2004 when the Nobel Prize in Chemistry was awarded “for 
the discovery of ubiquitin-mediated protein degradation.” 
 
THE UBIQUITIN-PROTEASOME SYSTEM 
The ubiquitin-proteasome system is involved in many cellular processes including 
differentiation, cell-cycle control, and DNA repair.  Two key steps are required for regulated 
proteolysis:  covalent attachment of a polyubiquitin chain onto the target substrate and 
delivery of ubiquitinated substrates to the proteasome complex for degradation. 
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Ubiquitination involves a complex enzymatic cascade that controls protein conjugation 
with ubiquitin.  This results in an isopeptide bond with lysine residues on the target 
substrate and, subsequently, with another ubiquitin to extend the ubiquitin chain.  Once 
ubiquitinated, protein substrates must be recognized and targeted to the proteasome 
complex, where they are unfolded and degraded.  The 26S proteasome is an ATP-
dependent multisubunit complex composed of a barrel-like 20S core complex flanked by 
one or two 19S regulatory complexes.  The 19S cap is thought to mediate recognition of 
ubiquitin-protein conjugates, catalysis of isopeptidase reactions to remove the 
polyubiquitin chain, and denaturation of the protein.   The substrate is then transported 
through the central channel where it is degraded at the active site by endopeptidases to 
produce short polypeptides.  
The first enzyme in the ubiquitin-proteasome pathway, E1 ubiquitin-activating 
enzyme, is encoded in Saccharomyces cerevisiae by the essential gene UBA1 (McGrath 
et al. 1991) and is required to catalyze the first step in all ubiquitin-mediated processes.  A 
single budding yeast E1 protein, Uba1, is responsible for initiating the intricate downstream 
ubiquitination network consisting of 11 E2s and 54 potential E3s that act on a multitude of 
proteins, marking them for destruction.  The increasing complexity of this pathway is 
regulated by increasing specificity of recognition between E2s and E3s, and then with 
these enzymes and the many varied protein substrates.  Once these substrates are 
polyubiquitinated however, the complex pathway again tapers to one end – the 26S 
proteasome—where the ubiquitinated substrates are recognized and broken down.   
The ubiquitin-proteasome pathway was originally thought to culminate in a 
stochastic interaction between polyubiquitin chains and the proteasome.  However, the 
selective recognition of ubiquitinated proteins is emerging as a key regulatory step in 
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proteolysis.  Protein recognition and targeting mechanisms must also be highly regulated 
in order to avoid indiscrimate degradation.  We have only begun to understand the 
complex mechanisms involved in targeting ubiquitinated proteins to the proteasome.  
Multiubiquitin chains bind Rpn10, a subunit of the 19S regulatory complex.  In addition to 
Rpn10, it has recently been shown that several proteasome-interacting proteins, including 
Rad23 and Dsk2, act as ubiquitin receptors in order to confer yet another level of substrate 
selectivity.  These proteins act as adaptors, associating with the proteasome via ubiquitin-
like domains (UbL) and recognizing ubiquitin chains via ubiquitin-associated domains 
(UBA).  One of the outstanding questions regarding the mechanistic details involved in 
substrate delivery is whether UbL/UBA proteins remain docked on the proteasome, 
awaiting ubiquitinated proteins, or first bind to ubiquitinated proteins and function to deliver 
them to proteasome complexes. 
 
RESEARCH OBJECTIVES 
The initial goal of this thesis was to create a rapid, powerful method for shutting 
down the ubiquitin-proteasome system in Saccharomyces cerevisiae.  This powerful tool 
would enable us to use a global approach to exploring unanswered questions regarding 
the regulation of the ubiquitin-proteasome system.  In the subsequent chapters of this 
thesis, I describe the generation of a new genetic mutant strain of S. cerevisiae and offer 
examples of how this strain can provide a unique perspective with which to better 
understand ubiquitin-dependent cellular processes.   
In chapter 2, I discuss in detail the genetic screen in which we created 
temperature-sensitive alleles of the essential ubiquitin-activating enzyme, UBA1, and 
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review initial phenotypic characterization of mutant alleles.  From this screen, uba1-204 
emerged as the first strong loss-of-function allele of the S. cerevisiae UBA1 gene.   
Chapter 3 was published as an article entitled “A conditional yeast E1 mutant 
blocks the ubiquitin-proteasome pathway and reveals a role for ubiquitin conjugates in 
targeting Rad23 to the proteasome” on March 14, 2007 in Molecular Biology of the Cell. 
Here, I discuss in further detail the full characterization of the conditional phenotype 
observed in uba1-204 cells.  Within five minutes of shifting mutant cells to the restrictive 
temperature, all detectable ubiquitin conjugates are lost.  Mutant cells exhibit a cell-cycle 
arrest phenotype and a defect in the proteolysis of several ubiquitin-proteasome pathway 
substrates.  These results establish uba1-204 cells as a rapid method of inhibiting the 
ubiquitin-proteasome pathway.  In analyzing the cellular effects of such a severe genetic 
assault, we observed that, while 26S proteasome complexes appeared structurally intact, 
they exhibited changes in their association with ubiquitin-binding receptor proteins, such 
as Rad23.   We conclude this chapter by exploring the significance of our observation that 
Uba1 activity is required for efficient targeting of ubiquitin-binding proteins to the 
proteasome.  Thus, we are able to exploit the unique ubiquitin chain-free cellular 
environment in the mutant strain to answer a question about the mechanism of ubiquitin 
receptor targeting in vivo that could not be easily addressed any other way. 
In chapter 4, I describe the results from a preliminary quantitative mass 
spectrometric analysis of proteasome complexes isolated from uba1-204 cells.  MudPIT, 
or multidimensional protein identification technology, allows identification and quantitation 
of proteins in a complex peptide mixture.  By coupling this powerful proteomic technique to 
the method of affinity-purifying intact proteasome complexes from yeast cells, it is possible 
to examine the impact of blocking the ubiquitin-proteasome pathway on the association of 
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proteins with the proteasome.  While this work is incomplete without validation of some of 
our results, it is included as further proof of the value of the uba1-204 tool described here 
to gain unique insight into the ubiquitin-proteasome system.  
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C h a p t e r  2  
SCREEN FOR TEMPERATURE-SENSITIVE ALLELES  
OF S. CEREVISIAE UBA1 
 
INTRODUCTION 
The 3075 base pair Saccharomyces cerevisiae ubiquitin-activating enzyme gene, 
UBA1, encodes a 1024 residue protein that is highly conserved throughout evolution 
(Figure 2-1).  There are two active sites on the E1 protein, the adenylation site and the 
active-site cysteine.  This drives the two-step enzymatic process in which two ubiquitin 
moieties can be bound simultaneously, with one forming an adenlyate intermediate while 
the other is transferred to the thiol site (Figure 2-2). 
 
Figure 2-1. Schematic representation of the S. cerevisiae E1 protein, Uba1.  
Uba1 contains 1024 residues with four conserved domains.  Domain I contains 
the nucleotide-binding motif and is found in many proteins, including those not 
involved in the ubiquitin pathway.  Domain III contains the active-site cysteine 
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residue.  Domains II and IV are found in several proteins but their function is not known 
(Hochstrasser, 1998).  Residues included in each domain are specified. 
 
Figure 2-2.  Activation of ubiquitin by E1.  E1 first interacts with ATP and 
ubiquitin to form a ubiquityl-AMP intermediate at its ATP binding site.  In a 
second reaction, the ubiquitin moiety is transferred to the E1 active-site cysteine 
residue to create a high-energy thioester linkage. 
The activation of ubiquitin and, therefore, all ubiquitin-dependent processes 
requires one key protein, E1.  Poised at the apex of the pathway, this protein provides a 
unique means of perturbing the entire downstream ubiquitin system.  Mutant alleles of E1 
have been instrumental in dissecting the functional significance of many aspects of the 
ubiquitin-proteasome system.  The first thermolabile E1 mutant was encountered in the 
ts85 derivative of the FM3A spontaneous mouse mammary carcinoma cell line (Finley et 
al. 1984).  These cells arrested in early G2 and late S phase and failed to degrade short-
lived proteins in vivo (Ciechanover et al. 1984).  Another mammalian E1 mutant, E36-ts20, 
was later identified in hamster lung fibroblast cells (Kulka et al. 1988).  This mutant 
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displayed similar defects in ubiquitin-protein conjugation and degradation of short-lived 
proteins.  Interestingly, these mutant cells also arrested at late S/early G2 phase.  A third 
E1 mutant, A31N-ts20, was found in Balb/c 3T3 mouse embryo fibroblast cells that had 
been subjected to chemical mutagenesis (Salvat et al. 2000).  Again, a defect was 
observed in the degradation of specific proteins, but like other mammalian mutants, a 
leaky E1 inactivation phenotype suggested that the E1 reaction is not rate-limiting in 
ubiquitination (Salvat et al. 2000).  
While examination of mammalian E1 mutants yielded valuable insights into the 
ubiquitin-proteasome system, there has been little work to characterize a strong allele of S. 
cerevisiae E1 enzyme since the first mutant alleles were described alongside original 
experiments to clone the gene (McGrath et al. 1991).  All yeast uba1 alleles that have 
been described previously are hypomorphic alleles that achieve only partial inactivation of 
the pathway.  In McGrath’s dissertation (1991), he described isolating three mutants of 
uba1, including uba1-26.  Uba1-26 is currently the most widely used mutant uba1 strain, 
often examined as a control in experiments studying various aspects of the ubiquitin-
proteasome system.  However, in initial experiments to determine the scope of its 
proteolytic defect, it was found that “the turnover of naturally short-lived proteins labeled 
during a 5 minute pulse…was unaffected in the ts26 mutant” (McGrath, 1991), indicating 
that the temperature sensitivity was not due to extensive protein stabilization.  In addition, 
these mutants were never well characterized, and the affect on ubiquitination was not 
examined.  Despite their leaky E1 inactivation phenotype, these mutant cells have proven 
useful in many studies of ubiquitin-dependent processes.  Palanimurugan et al. (2004) 
used uba1-26 with other ubiquitin pathway mutants to establish the ubiquitin-dependent 
degradation of Oaz1.  Gandre and Kahana (2002) observed moderate stabilization of Ub-
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R-LacZ.  While the observed protein stabilization was a sufficient control to establish the 
ubiquitin dependence of the turnover of these specific proteins, it is doubtful that this 
mutant would be useful for broader shutdown of the ubiquitin-proteasome system.  
Meanwhile, the uba1-2 allele was isolated in a screen for defects in Deg1-βgal 
degradation and was caused by a transposon insertion upstream of the coding sequence, 
resulting in reduction of wild-type Uba1 protein expression.  This allele results in only ~3-
fold stabilization of Leu-βgal, Ub-Pro-β gal, and Ste3, and only “modest stabilization” of 
short-lived proteins α2 and a1 (Swanson and Hochstrasser 2001).  Finally, other alleles 
were subsequently isolated as suppressors for various genetic mutations (uba1-165 
suppressed mcm3-10 in Cheng et al. 2002; uba1-o1 suppressed orc2-1 in Shimada et al. 
2002), but their mutant phenotypes are defined only in the context of their respective 
screens.   
The limitations of existing uba1 alleles motivated our initial screen to isolate a 
strong loss-of-function uba1 allele.  This is the first direct screen to isolate a conditional 
yeast E1 gene since the gene was first cloned in 1991 (McGrath et al. 1991).  Whereas 
most other mutants had been isolated in screens for various genetic pathways, which were 
not directly related to the ubiquitin-proteasome system, we employ a more direct “reverse 
genetic” approach.  By directly mutagenizing the gene of interest, a large population of 
potential conditional alleles is generated.  Furthermore, the method of error-prone PCR 
mutagenesis described can yield a wide spectrum of mutant phenotypes that had not been 
created before.  Whereas earlier hypomorphic alleles have proven useful in confirming the 
ubiquitin dependence of the turnover of specific proteins, they highlight the potential value 
of a stronger conditional allele with broad utility in exploring the entire ubiquitin conjugation 
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pathway.  Among the many issues that could be addressed with a tight and rapid-acting 
temperature-sensitive mutation in UBA1 is the question of how ubiquitin conjugates 
contribute to the proteasomal targeting of substrates destined for proteolysis.   
 
RESULTS 
Generation of mutant alleles of UBA1 by random PCR mutagenesis 
Error-prone PCR was performed using the Genemorph II Random Mutagenesis Kit 
(Stratagene, La Jolla, CA) according to protocols listed in the product specifications, using 
a target DNA amount ranging from <0.1 to 1000 ng in order to produce a wide range of 
mutation frequencies.  A large amount of target DNA (500-1000 ng) is recommended to 
achieve a low mutation frequency (0-4.5 mutations/kb), while using a lower amount of 
target DNA (0.1-100 ng) results in higher mutation rates (>9 mutations/kb).  The mutant 
uba1 gene products from the various PCR reactions were pooled and co-transformed into 
RJD3268 cells, along with pRS313 plasmid that had been linearized with NheI.  It is 
notable that the mutant strain isolated in this screen, uba1-204, was the result of a 
mutation rate of 4.5 mutations/kb (Figure 2-12). 
 
Genetic screen for temperature-sensitive phenotype 
A plasmid shuffling strategy was used to isolate cells that contained a genomic 
deletion of the essential UBA1 gene and carried only a mutant copy of the gene.  The 
entire coding region at one locus in a diploid W303 wild-type yeast strain was replaced 
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with the KanMX marker.  Gene disruption was verified by PCR and by sporulation and 
tetrad dissection.  The resulting strain, RJD3267 also contained a partial deletion of the 
overlapping Ste6 gene, causing sterility in mating type a cells.  Mutant plasmids were 
introduced into uba1∆ haploid cells sustained by a low copy URA3 plasmid containing 
UBA1.  Transformants were plated on 5-fluoro-orotic acid (5-FOA) to evict the UBA1 
plasmid and clones sustained by the mutagenized plasmid were sought (Figure 2-3). 
Plates were replica plated onto YPD plates and stored at 37°C to score for temperature 
sensitivity (Figure 2-3). 
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Figure 2-3.  Schematic of the plasmid shuffling strategy employed to isolate 
mutant alleles of UBA1.  The gene was deleted in diploid W303 cells by PCR 
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and replaced with the Kanmx marker.  Wild-type UBA1 was introduced into cells on 
the pRS316 URA3 plasmid.  Cells were sporulated and a haploid clone was 
isolated.  The strain was then transformed with PCR-mutagenized UBA1 and a 
linearized HIS5 plasmid that contained regions of homology to the PCR product.  
Transformants were replica plated onto 5-FOA plates to identify clones, which 
had lost the URA3 plasmid.  Plates were replica plated onto YPD plates and 
stored at 37°C to score for temperature sensitivity. 
After selecting for replacement of the URA plasmid with the HIS plasmid harboring 
the mutagenized PCR product, colonies were replica plated onto duplicate YPD plates and 
incubated at 25°C and 37°C (Figure 2-4).  We identified fifty clones which grew at 25°C but 
not at 37°C.  
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Figure 2-4.  Sample of temperature-sensitive uba1 mutants.  Strains were 
plated onto YPD and incubated at 25°C and 37°C to verify temperature-sensitive 
phenotype of isolated clones.   
 
Considering the failure of most E1 mutant alleles isolated in mammalian cells and 
in yeast to produce a discernable effect on bulk ubiquitin conjugation, we did not test 
directly for ubiquitination defects.  However, these previously characterized E1 mutants 
were found to stabilize specific proteins (Salvat et al. 2000; Palanimurugan et al. 2004).  
Uba1 mutants were tested for stabilization of a well-characterized short-lived substrate of 
the ubiquitin-proteasome pathway, UbV76-V-βgal (Johnson et al. 1995). UbV76-V-βgal is a 
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ubiquitin-βgalactosidase fusion protein in which the carboxy-terminal glycine residue of 
ubiquitin is mutated to a valine residue.  This mutation blocks ubiquitin cleavage, rendering 
the fusion protein unstable in vivo.  The “non-removable” N-terminal ubiquitin fusion protein 
is targeted for degradation by the UFD (Ubiquitin Fusion Degradation) pathway (Johnson 
et al. 1995).  An initial test of protein stabilization was conducted using wild-type and 
mutant cells expressing UbV76-V-βgal under control of the GAL1 promoter.  Of the fifty 
isolated clones, most showed little stabilization of the substrate protein at the 
nonpermissive temperature (Figure 2-5, ts93 and ts211).  However, this initial screen for 
proteolytic defects lead us for focus on four clones for further analysis:  ts60, ts108, ts126 
(Figure 2-5), and ts204 (also referred to as uba1-204). 
 
 
 
Figure 2-5.  Sample of initial UbV76-V-βgal substrate stabilization experiment.  
Wild-type and mutant cells expressing UbV76-V-βgal under control of the GAL1 
promoter were grown in SD medium with raffinose and protein expression was 
induced by addition of 2% galactose for 1 hour.  Cultures were then incubated at 
either 25°C or shifted to 37°C for 1 hour and transferred to dextrose medium 
pre-equilibrated at the same temperature to initiate a chase.  Samples were 
withdrawn at indicated time points, lysed, separated by SDS-PAGE, and 
immunoblotted with antiserum to β-gal. 
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Characterization of four temperature-sensitive alleles of UBA1  
Repeating the analysis of the turnover of UbV76-V-βgal in the four isolated uba1 
mutants verified that the substrate is degraded at permissive temperature but stabilized at 
the nonpermissive temperature (Figure 2-6).  Cell growth was tested, and all four mutant 
alleles remained viable at 30°C and were completely inviable at 37°C (Figure 2-7).  In 
addition, in all four mutant strains, cellular division ceased within one cell cycle of shifting 
cells to nonpermissive temperature (Figure 2-8). 
 
 
Figure 2-6.  Four temperature-sensitive alleles of uba1 stabilize UbV76-V-βgal, at 
the nonpermissive temperature.  Wild-type and mutant cells expressing UbV76-V-
βgal under control of the GAL1 promoter were grown in SD medium with 
raffinose and protein expression was induced by addition of 2% galactose for 1  
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hour.  Cultures were then incubated at either 25°C or shifted to 37°C for 1 hour and 
transferred to dextrose medium pre-equilibrated at the same temperature to 
initiate a chase. Samples were withdrawn every fifteen minutes for analysis.  
Lysates were separated by SDS-PAGE and immunoblotted with antiserum to    
β-gal.  Control (-) sample was an isogenic strain lacking the plasmid. 
 
 
 
Figure 2-7.  Growth defect at 37°C.  Four temperature-sensitive alleles of uba1 
grow at 25°C and 30°C but failed to grow at the nonpermissive temperature, 
37°C. 
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Figure 2-8.  Cell growth in YPD medium measured by optical density.  Mutant 
cells’ growth is similar to wild-type at 25°C but in all four mutants, cellular 
division ceased within one cell cycle of shifting cells to 37°C.   
 
In order to ascertain whether the proteolytic defect observed in uba1 mutants 
would extend to other E2/E3 degradation pathways, the turnover of Deg1-GFP was 
analyzed.  The Deg1 degradation signal found in the N-terminus of the yeast α2 repressor 
marks this protein for rapid degradation in vivo by the ubiquitin ligase Doa10 (Swanson et 
al. 2001).  The turnover of this protein after a cycloheximide chase was followed and three 
mutants, ts108, ts126, and ts204 displayed stabilization of the protein at 37°C (Figure 2-9). 
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Figure 2-9.  Stabilization of Deg1-GFP substrate.  Wild-type and uba1-204 cells 
expressing Deg1-GFP were grown in SD medium.  Cultures of exponentially 
growing cells were incubated at 25°C or shifted to 37°C for 1 hour and 
cycloheximide was added to initiate a chase period.  Samples were withdrawn 
every thirty minutes for analysis.  Lysates were separated by SDS-PAGE and 
immunoblotted with antiserum to GFP.  Control (-) sample was an isogenic strain 
lacking the plasmid. 
The four mutant alleles were then tested for an effect on the amount of high 
molecular-weight ubiquitin conjugates present in cells within three hours of shifting the 
cells to the nonpermissive temperature.  In lysates isolated from three of the alleles (ts60, 
ts108, and ts126), there was no discernable change in the amount of ubiquitin conjugates 
(Figure 2-10).  This result was expected, as earlier E1 mutants showed a similarly weak 
inhibition of bulk ubiquitination.  Surprisingly, lysates purified from ts204 (hereafter referred 
to as uba1-204) cells seemed to be completely lacking all detectable ubiquitin conjugates 
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within one hour of incubation at 37°C (Figure 2-10).  The experiment was repeated, 
analyzing samples each minute after the shift to nonpermissive temperature.  Amazingly, 
in uba1-204 cells, ubiquitin conjugates disappeared within five minutes of the temperature 
shift (Figure 3-2).  This dramatic result lead us to focus our efforts on this exceptionally 
strong mutant allele UBA1.    
 
 
Figure 2-10.  Loss of ubiquitin conjugates at the nonpermissive temperature in 
uba1-204 cells.  Wild-type and mutant uba1 cells were grown to log phase in 
liquid YPD medium at 25°C.  Half of each culture was shifted to the 
nonpermissive temperature and samples were withdrawn at indicated time 
points.  Lysates were prepared and analyzed by SDS-PAGE and immunoblotted 
with antiserum to ubiquitin. 
 
Characterization of uba1-204, a loss-of-function allele of UBA1  
Most cells containing mutations in the ubiquitin pathway exhibit some type of cell-
cycle arrest.  While the two mammalian E1 mutants (ts20 and ts85), derived from different 
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cell lines, both arrest at S/G2 boundary at restrictive temperatures (Ciechanover et al. 
1984; Finley et al. 1984; Kulka et al. 1988).  However, most yeast E1 mutants isolated 
thus far do not display a cell-cycle phenotype (McGrath, 1991; Swanson and Hochstrasser 
2000).  Only the cold-sensitive uba1-165 mutant has a cell-cycle phenotype, arresting in 
G1 (Cheng et al. 2002).  We postulated that the lack of cell-cycle arrest phenotypes 
observed in previously isolated yeast mutants could be due to their relatively mild 
phenotypes.  Therefore, we expected that the relatively severe ubiquitination defect 
observed in uba1-204 cells would be reflected in a defect in cell-cycle progression.  
However, microscopic analysis failed to reveal a clear cell-cycle arrest terminal phenotype 
(data not shown), although cellular division had ceased within one cell-cycle of shifting 
cells to the nonpermissive temperature (Figure 2-8).  
To more closely examine the effect of uba1-204 mutations on cell-cycle regulation, 
cellular DNA content was analyzed by flow cytometry.  Intriguingly, it seemed that while 
wild-type cells continued their progression through the cell-cycle at 37°C, mutant cells 
arrested with some cells remaining in G1 and some in G2 (Figure 2-11).  In later 
experiments discussed in chapter 3, our data reveal that uba1-204 cells can arrest both in 
G1 and in G2.  By synchronizing cells with alpha-factor and shifting them to the 
nonpermissive temperature during G1, we were able to demonstrate a G1 arrest 
phenotype (Figure 3-1C).  Similarly, when cells were allowed to progress through the cell-
cycle before shifting to 37°C, cells exhibited a G2 arrest phenotype (Figure 3-1D).  
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Figure 2-11.  Cell-cycle arrest.  Unsynchronized wild-type and uba1-204 cells 
were grown to log phase at 25°C in YPD medium and shifted to 37°C at time 0.  
At indicated time points following the temperature shift, aliquots were withdrawn 
and prepared for assessment of total DNA content by fluorescence-activated cell 
sorting (FACS). 
The viability of the mutant uba1-204 strain at the nonpermissive temperature was 
tested.  The number of colony forming units (CFU) per microliter in cultures of wild-type 
and uba1-204 cells was determined at various times after the shift to 37°C by plating cells 
on YPD and counting colonies after two days of growth at 25°C.  Uba1-204 cells remain 
viable for up to an hour at the nonpermissive temperature after which there is a rapid loss 
of cell viability (Figure 2-12).  Indeed, it was later discovered that when uba1-204 cells 
incubated at 37°C for an hour are returned to 25°C, ubiquitin conjugates rapidly reappear 
(Figure 3-2B).   
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Figure 2-12.  Cell viability.  Cells were inoculated at low density in YPD medium 
and grown to log phase.  At time 0, cultures were shifted to 37°C, and at 
indicated time points, samples were withdrawn and serially diluted.  Five 
microliters of each dilution was plated onto YPD plates and incubated at 25°C 
for 2-3 days.  The colony-forming units per microliter (CFU) were determined.  
Values represent percent CFU relative to time point 0 (25°C).   
 
Sequence analysis 
The mutant gene was sequenced and found to carry a total of fourteen mutations 
in its 3075 base coding sequence.  This is equivalent to a mutation frequency of 4.6 
mutations/kb.  Six of the mutations were silent and the remaining mutations resulted in 
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eight amino acid changes to the 1024 residue protein: D318G, K401E, V502A, E523G, 
E534G, N630G, F680S, D936E.   
 
 
Figure 2-13.  Protein sequence of Uba1-204.  Residues of the adenylation site, 
active site, and phosphorylation site are underlined.  Eight amino acid changes 
identified in mutant protein are listed below the sequence.   
 
The DNA of the other three isolated temperature-sensitive mutant genes was also 
sequenced in order to uncover any identical mutations or mutational “hot spots” which 
might provide a clue about key residues required for enzymatic activity (data not shown).  
However, none of the three mutant genes carried a mutation affecting the eight residues 
implicated in the conditional phenotype found in uba1-204.  
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DISCUSSION 
In generating a strong loss-of-function allele of yeast E1, we reflected on the 
reasons that such a mutant had not been previously isolated, despite its obvious value.  A 
key factor in the leaky inactivation phenotype observed for Uba1 mutants is the nature of 
the Uba1 protein itself, as an essential activator of all ubiquitin-dependent processes.  
Furthermore, it is known that the E1 reaction is much faster than downstream conjugation 
reactions (Pickart and Cohen 1994).  Because the activation of E1 is not rate limiting, a 
leaky mutant may provide enough E1 activity to drive most ubiquitin-dependent processes 
without resulting in an observable change in proteolysis.  Therefore, decreasing the 
abundance or activity of E1 enzyme could affect various E1-dependent cellular processes 
differently.   
Certainly one reason for the lack of a distinctly severe proteolytic defect is that 
most existing uba1 alleles had arisen spontaneously in the course of other, indirect 
“forward genetic” screens.  For example, uba-165 was isolated as a suppressor of mcm3-
10 when it was found to restore the interaction of Mcm3-10 mutant protein with other 
subunits of the MCM (minichromosome maintenance) complex, which is involved in DNA 
replication (Cheng et al. 2002).  However, it would be surprising to isolate an E1 allele with 
a broad defect in proteolysis as a spontaneous mutation in such a specific screen.  A 
defect in E1 ubiquitin activation would be expected to affect many ubiquitin-dependent 
processes, including DNA repair, translation, and endocytosis, in addition to proteolysis.  
The leaky Uba1 inactivation in existing uba1 mutant strains motivated our initial 
“reverse genetic” screen, in which we directly mutagenized the UBA1 gene.  Although this 
screen identified fifty temperature-sensitive alleles, only four displayed a clear defect in 
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proteolysis.  This result mirrors those from the original hydroxylamine mutagenesis of 
UBA1 (McGrath, 1991).  Similarly, the uba1-2 allele was isolated in a screen for defects in 
Deg1-βgal degradation, yet other proteins were only mildly stabilized (Swanson and 
Hochstrasser 2001).  Based on these results, we hypothesize that most mutant alleles 
may target specific interactions between E1 and the many diverse E2 enzymes, thus 
inactivating only subsets of the overall ubiquitin-proteasome pathway.  Indeed, in vitro, the 
rates of thiol ester formation from E1 to various purified E2 enzymes differs (Haas et al. 
1988).  This may explain the finding that in most E1 mutants, while turnover of specific 
proteins is inhibited, there is no severe defect in bulk ubiquitination, a result first seen in 
mammalian E1 mutants. The A31N-ts20 mutant showed a dramatic reduction in E1 to only 
5%-10% of the original amount.  This resulted in reduced ubiquitin conjugation onto 
specific proteins, such as p53 and c-Jun, but very mild reduction in bulk ubiquitin-protein 
conjugates (Salvat et al. 2000).  
Based on our understanding of these previously isolated mutants, we incorporated 
two key features into the design of our genetic screen.  First, a large library of uba1 
mutants with a broad mutation profile was created using the Stratagene Genemorph II 
Random Mutagenesis Kit.  This system utilizes two different polymerase enzymes to 
introduce a uniform mutational profile, generating a similar frequency of A and T mutations 
and C and G mutations.  In addition, the mutational frequency can be controlled by 
modulating the ratio of polymerase to target DNA.  We created a library with a mutational 
range from 1 to 20 mutations per thousand base pairs.  Directed evolution studies often 
use mutational frequencies of between 1 and 4 amino acid changes per protein (You and 
Arnold, 1996), while proteins with improved activity have been isolated with up to 20 
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mutations per protein (Daugherty et al. 2000).  The uba1-204 allele was the result of a 
mutation rate of 4.6 mutations/kb.  In addition, error-prone PCR is preferential to less-
efficient methods used to create earlier alleles, such as hydroxylamine mutagenesis, which 
only gives G:C and A:T transitions (McGrath, 1991), and upstream transposon insertion, 
which does not alter the coding sequence (Swanson and Hochstrasser 2001).  Using this 
error-prone PCR strategy, we created a larger library of uba1 mutants to screen for the 
most severe phenotype.  
The second key step in isolating a strong loss-of-function mutant from this large 
library was our screening method.  Based on the observation that in most E1 mutants 
specific substrates are stabilized while turnover of others is unaffected, we analyzed our 
resulting fifty candidate mutants by following the turnover of multiple diverse substrate 
proteins.  Therefore, uba1-204 is a unique allele of E1 in that it was the product of direct 
mutagenesis of the wild-type gene, and was isolated by screening for broad defects in 
proteolysis.   
While the structure for the S. cerevisiae E1 protein has not been solved, the crystal 
structure of similar activating enzymes can provide clues into the structural features 
present in Uba1.  Escherichia coli MoeB and MoaD proteins are involved in molybdenum 
cofactor biosynthesis, and their catalysis reactions are mechanistically similar that of E1.  
Active site residues 1 to 250 and 400 to 660 of MoeB are 17% and 22% similar to human 
UBA1, respectively (Lake et al. 2001), and MoaD displays the same fold and C-terminal 
Gly-Gly motif as ubiquitin (Rudolph et al. 2001).  Indeed it is believed that these genes and 
ubiquitin and E1 may be derived from related ancestral genes (Rajagopalan 1997).  When 
comparing the Saccharomyces cerevisiae UBA1 sequence to the multiple sequence 
alignment of MoeB and human E1, only one mutation, V502A, lies in a region for which a 
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structural role has been assigned.  This residue is conserved in the human sequence 
and resides adjacent to alpha helix 4, which is known to interact with the ATP molecule.   
 The structure of Uba3-APPB1, the activating enzyme for the ubiquitin-like protein 
NEDD8, has also been solved and can provide clues into possible structural features of 
Uba1 (Walden et al. 2003).  When comparing these structures to the known sequence of 
uba1-204, it again become clear that the V520A mutation in helix 4 disrupts a residue that 
is known to contact the adenylation domain in the structurally similar Uba3-APPBP1 
complex (Walden et al. 2003).  In addition, the N630G mutation lies near the active-site 
cysteine in loop 9 and may affect protein folding necessary for the interaction with 
ubiquitin.  While it is unclear how these specific mutations alter protein folding or activity, it 
is noteworthy that of the eight mutations found in the uba1-204 sequence, four of them 
result in replacement of an acidic residue with glycine.  Current research being done on 
the structure of E1, as well as other structurally similar proteins such as Uba3-APPB1 and 
the MoeB complex, may help to shed light on the functional consequences of mutating 
specific residues of these activating enzymes.   
 
MATERIALS AND METHODS 
Generation of mutant alleles 
Error-prone PCR was done using Genemorph II Random Mutagenesis Kit 
(Stratagene, La Jolla, CA) according to protocols listed in the product specifications, using 
a target DNA amount ranging from <0.1ng to 1000ng in order to produce a wide range of 
mutation frequencies.  A large amount of target DNA (500-1000ng) is recommended to 
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achieve a low mutation frequency (0-4.5 mutations/kb), while using a lower amount of 
target DNA (0.1-100ng) results in higher mutation rates (>9 mutations/kb).  The target 
DNA used was RDB1837, which contained wild-type UBA1 cloned from W303 S. 
cerevisiae cell and primers used for amplification were NG19 (5'-
CCGCTCGAGGGTAAAGTGGTTGAGCGAGGTA-3') and NG20 (5'-
GGACTAGTGAATTGCCATTACGCTTCC-3'; XhoI and SpeI sites underlined). The mutant 
uba1 gene products from the various PCR reactions were pooled and cotransformed into 
RJD3268 cells, along with pRS313 plasmid that had been linearized with NheI.   
A plasmid shuffling strategy was used to isolate cells that contained a genomic 
deletion of the essential UBA1 gene and carried only a mutant copy of the gene.  The 
entire coding region at one locus in a diploid W303 wild-type yeast strain was replaced 
with the KanMX marker, cells were grown in YPD for 12 hours to permit expression of 
KanMX, and selected by plating onto YPD plates containing 200 µg/ml Geneticin G-418 
Sulfate (Invitrogen, Carlsbad, CA).  Gene disruption was verified by PCR and by 
sporulation and tetrad dissection.  The resulting strain also contained a partial deletion of 
the overlapping Ste6 gene, causing sterility in mating type a cells.   
Transformants were plated onto –His plates to select for gapped plasmids which 
had recombined with uba1 PCR product and later replica plated onto plates containing 5-
fluoro-orotic acid in order to isolate clones which had lost the URA3 plasmid. 
 
Isolation of plasmids from yeast cells for sequence analysis 
Yeast strains were grown to log phase at 25°C in rich medium and a 1.5 ml aliquot 
was centrifuged.  Plasmids were rescued using the QIAprep Spin Miniprep Kit (Qiagen, 
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Valencia, CA).  Cell pellets were resuspended in 250 ul buffer P1 and 250 ul glass 
beads and vortexed for 5 minutes.  350 ul of buffer N3 was immediately added and 
samples were centrifuged for 10 minutes at high speed.  Supernatant was applied to 
QIAprep spin column and centrifuged for 45 seconds.  Column was washed with 750 ul of 
buffer PE and centrifuged for 45 seconds.  Column was placed in a clean tube and 50 ul of 
buffer EB was used to elute plasmid DNA by centrifuging sample for 1 minute.  1-2 ul of 
the resulting sample was used to transform E. coli cells.  Plasmids were purified from 
these transformed bacterial cells and sequenced. 
  
 Ubiquitination and degradation assays  
Described in detail in chapter 3, materials and methods.  
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C h a p t e r  3  
A CONDITIONAL YEAST E1 MUTANT BLOCKS THE UBIQUITIN-
PROTEASOME PATHWAY AND REVEALS A ROLE FOR 
UBIQUITIN CONJUGATES IN TARGETING RAD23 TO THE 
PROTEASOME 
(Published in Molecular Biology of the Cell, 18, 1953-1963) 
 
 
ABSTRACT 
E1 ubiquitin-activating enzyme catalyzes the initial step in all ubiquitin-dependent 
processes.  We report the isolation of uba1-204, a temperature-sensitive allele of the 
essential S. cerevisiae E1 gene, UBA1.  Uba1-204 cells exhibit dramatic inhibition of the 
ubiquitin-proteasome system, resulting in rapid depletion of cellular ubiquitin conjugates 
and stabilization of multiple substrates.   We have employed the tight phenotype of this 
mutant to investigate the role ubiquitin conjugates play in the dynamic interaction of the 
UbL/UBA domain adaptor proteins Rad23 and Dsk2 with the proteasome.  Although 
proteasomes purified from mutant cells are intact and proteolytically active, they are 
depleted of ubiquitin conjugates, Rad23, and Dsk2.  Binding of Rad23 to these 
proteasomes in vitro is enhanced by addition of either free or substrate-linked ubiquitin 
chains.  Moreover, association of Rad23 with proteasomes in mutant and wild-type cells is 
improved upon stabilizing ubiquitin conjugates with proteasome inhibitor.  We propose that 
  
33 
recognition of polyubiquitin chains by Rad23 promotes its shuttling to the proteasome in 
vivo.  
 
INTRODUCTION 
Activation of ubiquitin by ubiquitin-activating enzyme (E1) is the requisite first step 
in all ubiquitin-dependent pathways, including regulated proteolysis.  The process begins 
with an ATP-dependent reaction in which the ubiquitin moiety forms a high-energy 
thioester bond with the active-site cysteine of E1.  E1 can then transfer the activated 
ubiquitin to a conjugating enzyme (E2), which acts alone or in conjunction with a ubiquitin 
ligase (E3) to covalently link ubiquitin to lysine residues on specific target proteins (Haas 
and Siepmann, 1997).  Through successive ligation reactions, a polyubiquitin chain can 
form on the substrate and serve as a signal for targeting to the multisubunit 26S 
proteasome.  Composed of a cylindrical 20S proteolytic core complex capped at one or 
both ends by 19S regulatory complexes, the proteasome deubiquitinates and unfolds 
substrates before translocating them into its core for proteolysis (Amerik and Hochstrasser 
2004; Pickart and Cohen 2004).  
The existence of mammalian cell lines that carry temperature-sensitive alleles of 
E1 has been of great importance to the study of the functions of the ubiquitin system in 
animal cells (Finley et al. 1984; Ciechanover et al. 1984; Kulka et al. 1988; Salvat et al. 
2000).  Ironically, no tight, rapid-acting conditional mutation has been described for the 
budding yeast UBA1 gene that encodes E1 despite the availability of sophisticated 
molecular genetic techniques in this organism.  Although a temperature-sensitive allele of 
UBA1 exists, this allele results in only moderate stabilization of tested substrates, and 
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possible defects in ubiquitination were not examined (McGrath 1991; Gandre and 
Kahana 2002).  A second allele resulting from a transposon insertion upstream of the 
UBA1 coding sequence reduced wild-type Uba1 protein function, causing inefficient 
degradation of some proteins (Swanson and Hochstrasser 2000).  Additional alleles were 
later encountered as suppressor mutations in various indirect genetic screens and also 
achieved only partial inactivation of the pathway (Cheng et al. 2002; Shimada et al. 2002).  
Whereas these hypomorphic alleles have proven useful in confirming the ubiquitin 
dependence of the turnover of specific proteins, they highlight the potential value of a 
stronger conditional allele with broad utility in exploring the entire ubiquitin conjugation 
pathway.  Among the many issues that could be addressed with a tight and rapid-acting 
temperature-sensitive mutation in UBA1 is the question of how ubiquitin conjugates 
contribute to the proteasomal targeting of substrates destined for proteolysis.   
While the enzymatic cascade responsible for polyubiquitination provides strict 
control of substrate tagging, the pathway was originally thought to culminate in a 
stochastic interaction between polyubiquitin chains and the proteasome.  On the contrary, 
recent work has shown that a diverse set of ubiquitin-binding receptors regulate the 
targeting of ubiquitinated proteins to the proteasome in a substrate-specific manner (Chen 
and Madura 2002; Elsasser et al. 2004; Verma et al. 2004; Wilkinson et al. 2001; reviewed 
in Elsasser and Finley 2005; Hicke et al. 2005).  The first polyubiquitin-binding receptor 
identified was Rpn10, a subunit of the 19S regulatory complex that contains a ubiquitin-
interacting motif (UIM) (Deveraux et al. 1994).  However, cells lacking Rpn10 exhibit only 
mild phenotypes, indicating that additional ubiquitin chain recognition mechanisms must 
exist (van Nocker et al. 1996).  A second class of polyubiquitin binding proteins, referred to 
as UbL/UBA proteins, is exemplified in yeast by the nucleotide excision repair protein 
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Rad23 (Watkins et al. 1993) and the spindle pole duplication factor Dsk2 (Biggins et al. 
1996).  UbL/UBA proteins specifically recognize polyubiquitin chains via C-terminal 
ubiquitin-associated (UBA) domains (Bertolaet et al. 2001b; Wilkinson et al. 2001; 
Hofmann and Bucher, 1996; Rao and Sastry 2002; Chen and Madura 2002; Raasi and 
Pickart 2003).  For example, Rad23 has two UBA domains that interact with 
polyubiquitinated proteins in a linkage-specific and chain length-dependent manner, 
preferentially binding to the K48-linked ubiquitin chains that serve as a degradation signal 
(Raasi and Pickart 2003).  In addition, these proteins interact with the proteasome via their 
N-terminal ubiquitin-like (UbL) domain (Walters et al. 2002; Schauber et al. 1998; Elsasser 
et al. 2002; Saeki et al. 2002).   
Integrating these two recognition motifs, UbL/UBA proteins, like Rpn10, are 
proposed to function as receptors that link polyubiquitinated proteins to the proteasome.  
Several lines of evidence support this receptor hypothesis.  In rad23 and dsk2 mutant 
cells, substrates are ubiquitinated but not degraded, consistent with a role in substrate 
delivery (Chen and Madura 2002; Funakoshi et al. 2002; Lambertson et al. 1999; Rao and 
Sastry 2002; Saeki et al. 2002; Wilkinson et al. 2001).  Moreover, both the UbL and UBA 
domains of Rad23 are essential for its role in promoting proteolysis (Lambertson et al. 
2003; Bertolaet et al. 2001b; Rao and Sastry 2002).  Most recently, it was shown that 
Rad23 and Rpn10 can directly promote proteasome binding and degradation of a 
ubiquitinated substrate in vitro, thereby establishing a direct receptor function for these 
proteins (Verma et al. 2004).  
UbL/UBA proteins are emerging as central players in selective proteolysis, and 
their interactions with numerous other ubiquitin-proteasome system (UPS) elements 
suggest a complex regulatory scheme, which remains poorly understood.  For example, 
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there are reports that UbL/UBA proteins may regulate substrate ubiquitination as well as 
proteasomal targeting.  The UbL domain of Rad23 binds the ubiquitin ligase Ufd2, which 
cooperates with the chaperone-like AAA ATPase Cdc48 and its cofactors to ubiquitinate 
specific substrates (Richly et al. 2005; Kim et al. 2004; Schuberth et al. 2004).  Moreover, 
when overexpressed, Rad23 and Dsk2 are capable of inhibiting proteolysis by binding a 
polyubiquitin chain on a substrate and inhibiting the ligation of additional ubiquitin 
molecules (Kleijnen et al. 2000; Ortolan et al. 2000).  Even the stoichiometry of receptor-
ubiquitin chain interactions is potentially complex given that Rad23 can form homodimers 
as well as heterodimers with the UbL/UBA protein Ddi1 (Bertolaet et al. 2001a; Bertolaet et 
al. 2001b; Kang et al. 2006) and that one polyubiquitin chain may simultaneously capture 
two receptor molecules (Kang et al. 2006; Lowe et al. 2006).  Finally, intramolecular 
interactions between UbL and UBA domains may function in regulating UbL/UBA protein 
activity (Walters et al. 2003; Ryu et al. 2003; Raasi et al. 2004).  
In this study, we isolate and characterize a novel allele of the yeast UBA1 gene, 
uba1-204, in which ubiquitin molecules are not efficiently assembled into chains or 
conjugated onto substrates.  We employ the resulting ubiquitin chain-depleted cellular 
environment to investigate the nature of ubiquitin-dependent proteasomal targeting. 
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RESULTS 
Isolation and phenotypic analysis of uba1-204 
The initial goal of this study was to create a loss-of-function allele of the S. 
cerevisiae ubiquitin-activating enzyme that resulted in strong and rapid inactivation of 
ubiquitin conjugation.  To generate mutant alleles, the UBA1 coding sequence, carried on 
a HIS3 plasmid and expressed from the natural UBA1 promoter, was subjected to random 
PCR mutagenesis.  Mutant plasmids were introduced into uba1∆ haploid cells sustained 
by a low copy URA3 plasmid containing UBA1.  Transformants were plated on 5-fluoro-
orotic acid to evict the UBA1 plasmid and clones sustained by the mutagenized plasmid 
were sought.  In a screen for temperature-sensitive growth, fifty candidate mutant alleles 
that grew at 25°C but failed to grow at 37°C were isolated.  To identify mutants that 
exhibited broad defects in the ubiquitin-proteasome system, we tested these alleles for 
loss of ubiquitin conjugates at the nonpermissive temperature.  Whereas the majority of 
these uba1 mutants largely retained ubiquitin conjugates at the nonpermissive 
temperature, uba1-204 mutant cells rapidly lost ubiquitin conjugates upon transfer to 37°C 
(data not shown).  The uba1-204 mutant gene was sequenced and found to contain 
mutations leading to eight amino acid alterations:  D318G, K401E, V502A, E523G, 
E534G, N630G, F680S, D936E.  Although none of the mutations occurred in close 
proximity to the adenylation site or the active-site cysteine, four mutations resulted in the 
replacement of acidic residues with glycine.  
  
38 
Cellular viability was unaffected in uba1-204 cells grown at temperatures ranging 
from the 25°C permissive temperature up to 33°C (Figure 3-1A).  Mutant cells began to 
exhibit loss of viability at 35°C and were completely inviable at 37°C (Figure 3-1A). 
Sensitivity to environmental stress is often a hallmark of ubiquitin pathway mutations, 
because stress leads to an increased requirement for protein quality control.  As predicted, 
compromised Uba1 activity conferred sensitivity to the cellular stressor cadmium chloride 
(Figure 3-1B).  Another important feature of the UPS is its critical role in the regulation of 
cell-cycle progression.  Whereas mammalian E1 mutants arrest at S/G2 (Finley et al. 
1984; Kulka et al. 1988; Goebl et al. 1988), the cold-sensitive yeast uba1-165 mutant has 
a G1 arrest phenotype (Cheng et al. 2002) and existing temperature-sensitive yeast E1 
mutants do not display a cell-cycle phenotype (McGrath, 1991; Swanson and 
Hochstrasser 2000).  In uba1-204 mutants, cellular division ceased within one cell-cycle of 
shifting cells to the nonpermissive temperature (data not shown).  To test the influence of 
the uba1-204 mutation on the cell-cycle, cellular DNA content was assessed by flow 
cytometric analysis.  When unsynchronized uba1-204 cultures were incubated at the 
nonpermissive temperature, a G2 arrest phenotype was apparent, with some cells 
continuing through the cell-cycle to arrest in G1 (Figure 2-10).  Next, we synchronized cells 
in G1 with α-factor prior to shifting them to 37°C.  Upon release into fresh medium at the 
nonpermissive temperature, wild-type cells progressed through the cell-cycle while uba1-
204 cells remained arrested at G1 (Figure 3-1C).  By contrast, when α-factor synchronized 
cells were released into fresh medium at the permissive temperature for 90 minutes to 
allow progression through the cell-cycle prior to shifting to 37°C, uba1-204 cells arrested at 
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G2 while wild-type cells did not (Figure 3-1D).  Therefore, uba1-204 mutant cells arrest 
at both G1 and G2 of the cell-cycle.  
 
 
 
Figure 3-1:  Uba1-204 cells are temperature-sensitive and undergo cell-cycle 
arrest.  (A) Ten-fold serial dilutions of wild-type and uba1-204 yeast cells were 
spotted onto YPD and (B) SD plates containing 30 µM CdCl2 and incubated at 
the indicated temperatures for 2-3 days.  (C) Wild-type and uba1-204 cells were 
arrested with α-factor for 2 hours at the permissive temperature.  The 
  
40 
temperature was shifted to 37°C for 1 hour and the cells were released into fresh 
medium at 37°C at time 0.  At indicated time points following release, aliquots 
were withdrawn and prepared for assessment of total DNA content by 
fluorescence-activated cell sorting (FACS).    (D) WT and uba1-204 cells were 
arrested with α-factor for 3 hours at the permissive temperature.  Cells were 
then released into fresh medium and grown at 25°C for 90 minutes to allow 
progression to G2 phase.  Cells were then shifted to 37°C at time 0 and aliquots 
were withdrawn and analyzed as in C. 
 
Uba1-204 cells are defective in ubiquitin conjugation and substrate degradation 
Complete inactivation of Uba1 should yield universal shutdown of downstream 
ubiquitination pathways.  To determine the extent of impairment to the UPS, the effect of 
the ubiquitin activation defect on overall ubiquitin conjugate accumulation was monitored.  
Strikingly, a nearly complete loss of detectable ubiquitin conjugates was observed within 
five minutes of shifting the cells to 37°C (Figure 3-2A).  The temperature-dependent defect 
in ubiquitin conjugate accumulation was partially reversed when cell cultures that were 
incubated at 37°C for one hour were returned to 25°C (Figure 3-2B).  To determine the 
impact of this reversibility on future experiments, we evaluated the restoration of 
ubiquitination activity in mutant cells incubated on ice.  Unexpectedly, it was observed that 
in uba1-204 cultures which were incubated at 37°C and then placed on ice, ubiquitin 
conjugates began to reappear within minutes (Figure 3-2C).  Therefore, to ensure full 
Uba1 inactivation in all future experiments, wild-type and mutant cells were maintained at 
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the restrictive temperature throughout centrifugation and preparation steps until they 
were flash-frozen in liquid nitrogen. 
 
 
 
Figure 3-2:  Uba1-204 cells are defective in ubiquitin conjugation.  (A) Wild-type 
and uba1-204 cells were grown to log phase in liquid YPD medium at 25°C.  Half 
of each culture was shifted to the nonpermissive temperature at time 0 and 
samples were withdrawn every minute.  Lysates were prepared and analyzed by 
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SDS-PAGE and immunoblotted with antiserum to ubiquitin.  (B) Loss of ubiquitin 
conjugation is reversible.  Strains were grown as in A and samples were shifted 
to the nonpermissive temperature for 1 hour.  At time 0, the temperature was 
shifted back to 25°C, aliquots were withdrawn at indicated time points and 
ubiquitin conjugation was assessed as in A.  (C) Uba1-204 cells are active in 
ubiquitin conjugation at 4°C.  Cells were grown in YPD medium and shifted to 
37°C for 1 hour.  At time 0, ice was added to cultures and the temperature was 
shifted to 4°C.  Samples were withdrawn and analyzed as in A 
 
The dramatic reduction in ubiquitin conjugate levels in uba1-204 cells at the 
nonpermissive temperature indicates that multiple downstream E2/E3 pathways were 
inactivated.  If this was indeed the case, stabilization of diverse proteasome substrates 
would be expected.  To test this, the turnover of a synthetic substrate, Deg1-GFP, was 
analyzed in a cycloheximide chase experiment.  Deg1-GFP bears the degradation signal 
from the rapidly degraded Matα2 protein and is a substrate for the ubiquitin ligase Doa10 
(Swanson et al. 2001).  At 25°C, the majority of Deg1-GFP was destroyed within 15 
minutes of terminating protein synthesis in both wild-type and mutant strains (Figure 3-3A).  
The protein was modestly stabilized in the wild-type cells at 37°C, but was completely 
stabilized in the uba1-204 cells at 37°C.  To examine the scope of this proteolytic defect, 
we also monitored turnover of UbV76-V-βgal, a cytosolic substrate of the UFD ubiquitin 
ligase pathway (Johnson et al. 1995).  Although degradation of UbV76-V-βgal occurred with 
normal kinetics following a galactose promoter shut-off in the mutant cells at 25°C, there 
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was no detectable degradation of the substrate in uba1-204 cells at 37°C (Figure 3-3B).  
In addition, ubiquitin-protein conjugates could be detected in the early time points of the 
wild-type samples at both temperatures and in the mutant samples at 25°C.  However, 
these conjugates were conspicuously absent in uba1-204 cells at 37°C. 
To determine the physiological significance of these turnover defects, we also 
assessed the effect of impaired ubiquitin activation on a well-characterized endogenous 
substrate, the cyclin-dependent kinase inhibitor Sic1.  At the G1/S boundary, Sic1 is 
polyubiquitinated by the SCF ubiquitin ligase and then degraded by the proteasome 
(reviewed in Deshaies, 1999).  Wild-type and mutant cells carrying a GAL-SIC1 allele were 
arrested with α-factor, Sic1 expression was transiently induced with a pulse of galactose, 
and cells were released from G1 into the cell-cycle.  Similarly to the test substrates, Sic1 
degradation was not impaired in uba1-204 cells at the permissive temperature, but the 
protein was stabilized at 37°C (Figure 3-3C).  These data confirm that in the uba1-204 
mutant, multiple downstream proteolytic pathways were inhibited. 
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Figure 3-3:  Uba1-204 cells are defective in substrate degradation.  (A) Wild-
type and uba1-204 cells expressing Deg1-GFP were grown in SD medium.  
Cultures of exponentially growing cells were incubated at 25°C or shifted to 37°C 
for 1 hour and cycloheximide was added to initiate a chase period.  Samples 
were withdrawn every fifteen minutes for analysis.  Lysates were separated by 
SDS-PAGE and immunoblotted with antiserum to GFP.  Control (-) sample was 
an isogenic strain lacking the plasmid.  (B) WT and uba1-204 cells expressing 
UbV76-V-βgal under control of the GAL1 promoter were grown in SD medium with 
raffinose and protein expression was induced by addition of 2% galactose for 1 
hour.  Cultures were then incubated at either 25°C or shifted to 37°C for 1 hour 
and transferred to dextrose medium pre-equilibrated at the same temperature to 
initiate a chase.  Samples were withdrawn every 15 minutes, lysed, separated 
by SDS-PAGE and immunoblotted with antiserum to β-gal.  (C) WT and uba1-
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204 cells expressing Sic1 under the control of the GAL1 promoter were grown in SD 
medium with raffinose and arrested with α-factor for 2 hours.  Sic1 expression 
was induced by addition of galactose to 2% and cells were incubated at 25°C for 
1 hour before shifting to 37°C for an additional hour.  Cells were then transferred 
to dextrose medium to initiate a chase and samples were withdrawn every 30 
minutes, lysed, separated by SDS-PAGE and immunoblotted with antiserum to 
Sic1.  Protein loading was verified by immunoblotting with antiserum to Cdc28. 
 
Uba1-204 cells contain intact and active proteasomes 
To address the impact of a ubiquitin activation defect further downstream in the 
ubiquitination pathway, we examined its affect on the proteasome.  Considering that many 
subunits of the proteasome can be ubiquitinated (Peng et al. 2003) and the proteasome 
has been suggested to undergo rapid cycles of assembly/disassembly (Babbitt et al. 
2005), we first investigated a possible role for polyubiquitination in the maintenance of fully 
assembled 26S proteasome complexes.  When the chromosomal locus encoding Pre1, an 
alpha subunit of the 20S core, is replaced by an allele tagged with a Flag epitope, it is 
possible to obtain intact, active 26S proteasome complexes by a single-step affinity 
purification method (Verma et al. 2000).  Proteasomes affinity purified from uba1-204 cells 
cultured at either 25 or 37°C were found to contain all 20S and 19S subunits with no 
detectible change in subunit composition (Figure 3-4A).  Quantitative mass spectrometric 
analysis of these samples also showed no significant alteration in subunit abundance in 
proteasomes purified from the mutant strain (data not shown).  The assembly state of the 
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purified proteasomes was further confirmed by subjecting samples to native gel 
electrophoresis.  Coomassie blue staining showed intact 20S core particle (CP) complexes 
as well as proteasomes with either one (R1P) or two (R2P) 19S regulatory particles 
attached (Figure 3-4B).  The ratios of various proteasomal subcomplexes in the mutant 
were comparable to that seen in wild-type.  Thus, a robust level of ongoing ubiquitination is 
not necessary to sustain proteasome complexes in vivo, making it possible to purify intact 
proteasomes from uba1-204 mutant cells. 
Next, we examined the functional consequences of E1 inactivation on these intact 
proteasomes.  Proteasome peptidase activity was tested by in-gel hydrolysis of the 
fluorogenic peptide substrate Suc-LLVY.  Peptidase activity was similar for 20S and 26S 
proteasomes purified from wild-type and uba1-204 cells (Figure 3-4C).  Purified 26S 
proteasomes were next evaluated for their ability to degrade a polyubiquitinated 
physiological substrate, Sic1 (Ub-Sic1).  High molecular-weight Ub-Sic1 conjugates were 
completely degraded upon incubation with proteasomes isolated from wild-type or uba1-
204 cells (Figure 3-4D).  Inhibition of proteolysis with the 20S proteasome inhibitor 
epoxomicin resulted in accumulation of deubiquitinated Sic1 (Figure 3-4D) (Verma et al. 
2002).  
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Figure 3-4:  26S proteasomes isolated from uba1-204 cells are properly 
assembled and proteolytically active.  (A) Intact 26S proteasomes can be 
purified from uba1-204 cells.  Wild-type and uba1-204 cells were incubated at 
25°C or 37°C for 40 minutes and 26S proteasomes were affinity purified as 
described in materials and methods.  Samples were resolved by SDS-PAGE and 
visualized by Coomassie blue staining.  19S and 20S subunits are specified.  (B) 
Purified proteasome complexes were resolved by nondenaturing PAGE and 
were visualized by Coomassie blue staining.  CP refers to 20S core particle, and 
R1P and R2P refer to 26S proteasomes with one or two regulatory caps, 
respectively. (C) Proteolytic activity of the complexes in the nondenaturing gel 
from B was detected by fluorogenic peptide overlay with the peptidase substrate 
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Suc-LLVY-AMC.  Fluorescent bands were visualized by exposure to UV light.  (D) 
Uba1-204 26S proteasomes are active in the degradation and deubiquitination 
of Ub-Sic1 in vitro.  26S proteasomes purified from wild-type and uba1-204 cells 
were incubated with Ub-Sic1 at 30°C for 5 minutes.  For deubiquitination 
reactions, proteasomes were preincubated with 100 µM epoxomicin for 30 
minutes at 30°C prior to incubation with Ub-Sic1.  Samples were analyzed by 
SDS-PAGE followed by immunoblotting with anti-Sic1 antibody.  
Polyubiquitinated Sic1 (Ub-Sic1) and deubiquitinated Sic1 are specified.  There 
is a band of unknown identity (*) that was reproducibly detected in the mutant 
but not wild-type lanes in the presence of epoxomicin. 
 
Ubiquitin-binding proteins have differential requirements for polyubiquitin in 
proteasome targeting 
Having established that cellular depletion of polyubiquitin chains does not alter 
proteasome activity, we next evaluated the association of known ubiquitin-binding factors 
with the proteasome.  Cell lysates were prepared from wild-type and mutant cells, and 
proteasome complexes were purified by immunoprecipitation as described.  Comparable 
levels of the 20S proteasome subunit Pre2 (tested with antibody to LMP7, the human 
homolog) were detected in all immunoprecipitation samples, verifying that equivalent 
amounts of intact proteasomes were purified from wild-type and uba1-204 cells (Figure 3-
5E).  As expected, there was a striking decrease in the association of ubiquitin conjugates 
with the 26S complex isolated from uba1-204 cells held at 37°C (Figure 3-5A).  Although 
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Rpn10 is the only validated ubiquitin-binding proteasome subunit, most cellular Rpn10 
remains free, unincorporated into proteasome complexes (van Nocker and Vierstra, 1993; 
Deveraux et al. 1994; Haracska and Udvardy 1995).  This had suggested the possibility 
that Rpn10, as well as Rad23 and Dsk2, may form transient interactions with the 
proteasome, cycling between a free and assembled form.  We therefore examined how 
the defect in ubiquitination impacted this potential equilibrium.  Analysis of purified 
proteasomes indicated that loss of polyubiquitination activity in uba1-204 cells did not alter 
Rpn10 incorporation into the proteasome complex (Figure 3-5D).  These data, verified by 
mass spectrometry, suggest that the interaction of Rpn10 with polyubiquitin chains is not 
necessary for its association with intact proteasome complexes.  In contrast, proteasomes 
isolated from uba1-204 at the restrictive temperature exhibited a significant decrease in 
the amount of associated UbL/UBA proteins Rad23 (Figure 3-5B) and Dsk2 (Figure 3-5C).   
Meanwhile, overall levels of both Rad23 and Dsk2 proteins in mutant cell lysates were not 
affected by the temperature shift.  Therefore, whereas both UbL/UBA receptor proteins 
were indeed present in cell lysates, they failed to associate efficiently with the proteasome 
upon inhibition of ubiquitin conjugate formation. 
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Figure 3-5:  26S proteasomes isolated from uba1-204 cells exhibit reduced 
content of UbL/UBA proteins.  (A-E)  Wild-type and uba1-204 cells expressing 
Pre1-FH were grown in casamino acid medium and half the cultures were 
shifted to 37°C for 40 minutes.  Lysates were prepared and immunoprecipitated 
as described in materials and methods by incubation with anti-Flag resin in the 
presence of ATP.  Intact 26S proteasomes were eluted with Flag peptide, 
separated by SDS-PAGE, and proteasome-bound proteins were detected by 
immunoblotting with antiserum to the specified proteins.  Antibody specificity 
was verified using deletion mutants. 
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Ubiquitin chains promote Rad23 association with the proteasome 
To examine the nature of ubiquitin conjugation-dependent receptor targeting in 
more depth, we focused on Rad23.  The dual recognition capability of UbL/UBA proteins 
like Rad23 underlies their adaptor function, but it is unclear whether ubiquitin chain binding 
occurs before or after proteasome binding.  The essentially ubiquitin-free nature of 
proteasomes purified from uba1-204 cells presented an ideal reagent with which to 
examine the ubiquitin-dependence of Rad23 targeting.  If the observed decrease in Rad23 
interaction with the proteasome was truly a result of its inability to locate ubiquitinated 
substrates, addition of such substrates would be expected to restore binding.  To test this 
hypothesis, we analyzed the effect of addition of the polyubiquitinated substrate, Ub-Sic1, 
on the ability of GST-Rad23 to bind to immobilized proteasomes in vitro.  As the results in 
Figure 3-6A illustrate, addition of Ub-Sic1 resulted in a marked increase in the binding of 
full-length GST-Rad23 to proteasomes.  A GST-UBA fusion protein that lacks the 
proteasome-binding UbL domain was unable to associate with the proteasome.  
Conversely, Rad23 lacking the UBA domains (GST-UbL) binds the proteasome regardless 
of whether Ub-Sic1 substrate is present (Figure 3-6A).  The Ub-Sic1-dependence of GST-
Rad23 targeting provides further support for the notion that Rad23 interaction with 
polyubiquitinated proteins can promote its shuttling to the proteasome.  Furthermore, to 
ensure that this response was independent of the GST tag, Rad23 fused to a His6 epitope 
was also tested with similar results (Figure 3-6B).   
A recent report demonstrated that Ub-Sic1 is preferentially delivered to the 
proteasome by either Rad23 or Rpn10 (Verma et al. 2004).  The capacity of Rad23 and 
other receptors to selectively target substrates for proteolysis suggests that in addition to 
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recognizing conjugated polyubiquitin chains, Rad23 may detect degradation signals 
within substrate proteins themselves.  To determine if recognition of a polyubiquitin chain 
is sufficient to enhance binding of Rad23 to the proteasome, free K48-linked tetra-ubiquitin 
chains (Ub4) were tested in the proteasome-binding assay.  The results in Figure 3-6C 
demonstrate that Ub4 was sufficient to stimulate GST-Rad23 recruitment to the 
proteasome and that the presence of conjugated substrate is not absolutely required to 
drive targeting in vitro.  To extend these conclusions to a cellular environment, the 
proteasome inhibitor MG132 was used to stabilize polyubiquitin chains in vivo.  Analysis of 
proteasomes from cells treated with the drug confirmed an increase in proteasome-bound 
Rad23 in both mutant and wild-type cells coincident with an increase in ubiquitin chains 
(Figure 3-6D).   
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Figure 3-6:  Polyubiquitin chains promote Rad23 binding to the proteasome. (A) 
Ub-Sic1 promotes association of full-length GST-Rad23 with proteasome.  
Sepharose-immobilized proteasomes isolated from uba1-204 cells were 
preincubated with proteasome inhibitors for 1 hour and then incubated with GST 
fusion proteins in the presence or absence of Ub-Sic1 as described in materials 
and methods.  GST-Rad23 refers to the full-length protein, whereas GST-UBA 
contains both UBA domains and lacks the UbL domain.  GST-UbL contains only 
the N-terminal UbL domain and was detected with antiserum to GST.  The 
presence of proteasome complexes was verified with antibodies to Rpn10.  As a 
negative control, simultaneous purification was conducted with uba1-204 cells 
lacking the Pre1-Flag allele (UT).  (B) Ub-Sic1 promotes association of Rad23-
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HIS with proteasome.  Immobilized proteasomes were prepared as in A and 
incubated with Rad23-HIS in the presence or absence of Ub-Sic1.  (C) Free 
tetraubiquitin chains are sufficient to promote GST-Rad23 association.  
Immobilized proteasomes were prepared as in A and incubated with GST-Rad23 
and Ub4 rather than Ub-Sic1. (D) Stabilization of polyubiquitin conjugates in vivo 
promotes Rad23 targeting to the proteasome.  Wild-type and uba1-204 cells 
were treated with MG132 or DMSO (-) and shifted to 37°C for 1 hour.  
Proteasomes were isolated by affinity purification, ubiquitin conjugates were 
detected with antiserum to ubiquitin, and Rad23 binding was assessed. 
 
DISCUSSION 
The initial goal of this study was to develop a method of inhibiting the entire 
ubiquitin-proteasome system in the budding yeast, Saccharomyces cerevisiae.  A single 
budding yeast E1, Uba1, initiates an intricate downstream ubiquitination network 
consisting of 11 E2s and 54 potential E3s that act on a multitude of proteins, marking them 
for destruction.  At the apex of the entire pathway, the essential E1 gene, UBA1, is the 
logical target to disrupt all downstream ubiquitination reactions.  Indeed, experiments 
conducted with a mouse cell line harboring a temperature-sensitive E1 provided the 
foundation for fundamental early discoveries on the nature of the UPS (Finley et al. 1984; 
Ciechanover et al. 1984; reviewed in Pickart and Cohen 2004).  Yet, while conditional 
mutants of the S. cerevisiae E1 gene had previously been isolated, they only exhibit partial 
loss-of-function phenotypes, limiting their utility (Swanson and Hochstrasser 2000; 
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McGrath et al. 1991; Cheng et al. 2002).  We reasoned that a strong, fast-acting, 
temperature-sensitive uba1 mutant would be a valuable tool to address the role of ubiquitin 
conjugation in myriad processes.  We show that it is possible to isolate such a mutant and, 
as a demonstration of its utility, we have used the uba1-204 mutant to explore the nature 
of ubiquitin chain recognition and delivery pathways. 
Phenotypic characterization of the uba1-204 mutant revealed that it exhibited 
dramatic loss of both polyubiquitin conjugates and proteolysis at the restrictive 
temperature.  Upon shifting mutant cells to 37°C, nearly all detectable ubiquitin conjugates 
disappeared in a matter of minutes, suggesting rapid inactivation of the mutant Uba1 
protein.  Moreover, the turnover of three proteins targeted by different ubiquitin ligases was 
severely inhibited in mutant cells held at the nonpermissive temperature.  Together, the 
rapid loss of conjugates and the stabilization of three different UPS substrates suggest the 
interruption of multiple downstream proteolytic pathways.  However, it is possible that 
there remains a level of ubiquitin activation sufficient to sustain some degradation 
pathways.  Clb2 did not accumulate in G1-arrested uba1-204 cells upon induction of its 
expression from a GAL promoter, whereas Clb2 lacking its destruction box did accumulate 
(A. Amon, personal communication).  This observation suggests that APC-dependent 
degradation of Clb2 may continue despite the otherwise severe defects seen in uba1-204.  
It will be interesting in the future to determine the proteome-wide effects of this mutation.  
To investigate the impact of polyubiquitin chain depletion on substrate delivery 
processes, we examined the ubiquitin-proteasome system at its terminus, the proteasome.  
We present evidence that while robust ubiquitination is not required for the maintenance of 
functional 26S proteasomes, it may regulate the recruitment of some ubiquitin binding 
proteins.  In the absence of normal ubiquitination, Rpn10 incorporation into the 
  
56 
proteasome complex was unaltered.  However, in extracts from uba1-204 mutant cells, 
proteasomes were associated with reduced levels of the UbL/UBA proteins Rad23 and 
Dsk2.  
Two models have been proposed to describe the mechanism of Rad23-mediated 
substrate delivery (reviewed in Madura 2004).  According to the “shuttle factor” model, 
Rad23 first recognizes polyubiquitinated proteins via its UBA domains and subsequently 
shuttles substrates to the 26S proteasome.  In contrast, the “alternative receptor” model 
predicts that Rad23 docks onto the proteasome via its UbL domain and acts alongside 
Rpn10 as a receptor for trapping polyubiquitinated substrates.  Because they can be 
isolated largely free of associated ubiquitin chains, proteasomes from uba1-204 cells 
provide a means of distinguishing between these two models by addressing the key 
question of whether Rad23 association with the proteasome depends on the availability of 
ubiquitinated substrates.  A decrease in proteasome-bound Rad23 was observed in the 
uba1-204 mutant.  Moreover, the results in Figure 3-6 demonstrate that addition of 
polyubiquitin chains (either unanchored or substrate-bound) to a polyubiquitin-free in vitro 
system promoted Rad23 association with the proteasome.  The defect in Rad23 targeting 
could also be rescued in vivo by increasing cellular polyubiquitin levels with the 
proteasome inhibitor MG132.  Based on these results, we propose that the recognition of 
ubiquitin chains typically precedes (and activates) proteasomal targeting of Rad23.  
Conversely, if detection methods accurately reflect a near absence of ubiquitin conjugates 
in the mutant, then the remaining Rad23 residing on proteasomes isolated from these cells 
hints that Rad23 can operate as postulated by the alternative receptor model, albeit less 
efficiently than it functions as a shuttling factor.  
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Recent findings have suggested that intramolecular interactions can regulate 
Rad23 activity, resulting in a “closed conformation” and steric inhibition of the receptor.  In 
hHR23a, the human homolog of Rad23, the UbL domain engages in a transient 
intramolecular interaction with both UBA domains (Walters et al. 2003).  NMR 
spectroscopic analysis of yeast Rad23 has revealed that while the first UBA domain can 
participate in an intramolecular interaction with the UbL, the carboxy-terminal UBA domain 
does not (Kang et al. 2006).  Intramolecular interactions could result in inhibition of 
intermolecular activity such as proteasome and ubiquitin chain binding.  This may explain 
the finding that full-length Rad23 has a lower affinity for the proteasome than does its 
truncated UbL domain (Elsasser et al. 2002) and removal of the UbL domain from intact 
hHR23a increases its affinity for free Ub6 chains four-fold (Raasi et al. 2004).  These 
biophysical data predict that addition of ubiquitin conjugates should stimulate Rad23 
association with ubiquitin-depleted proteasomes in vitro, and that depletion of ubiquitin 
conjugates in vivo should lead to reduced association of Rad23 with the proteasome, 
whereas accumulation of ubiquitin conjugates should enhance Rad23 association with the 
proteasome.  All three of these predictions have been confirmed in this report.  Taken 
together, the data suggest that in its “resting” state, Rad23 is in a closed conformation in 
which the UbL and first UBA domain engage in an intramolecular association.  Upon 
coming into contact with substrate, the UBA domain preferentially binds the substrate’s 
ubiquitin chain owing to its ten-fold higher affinity for ubiquitin compared to UbL (Ryu et al. 
2003).  The exposed UbL domain can now bind to the proteasome.  Although binding of 
Rad23’s UBA domains to polyubiquitin and its UbL domain to proteasome may be 
sequential, the process is not necessarily unidirectional.  It is possible that disruption of the 
weak UbL-UBA intramolecular interaction could occur either through UBA recognition of a 
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polyubiquitin chain or through binding of UbL to proteasome, which could account for the 
presence of low amounts of Rad23 on proteasomes purified from uba1-204 cells.  
Nevertheless, whether this binding is truly due to docking of “empty” receptor molecules or 
is merely an artifact of residual Uba1 activity, our data clearly demonstrate that ubiquitin 
chains significantly enhance stable association of Rad23 with the proteasome in vitro and 
in vivo.  
In summary, we have isolated and characterized a new allele of budding yeast 
ubiquitin-activating enzyme that results in nearly complete inhibition of the ubiquitin-
proteasome pathway.  Our data reveal that while ongoing ubiquitination is not necessary 
for proteasome activity, ubiquitin conjugates promote the association of ubiquitin-binding 
substrate receptor proteins with the proteasome.  In addition to regulated proteolysis, 
ubiquitin is involved in a broad range of other cellular functions, including cell-cycle control, 
transcription, DNA repair, signal transduction, and endocytosis.  Mutant uba1-204 cells will 
be a valuable tool in further exploration of ubiquitin-dependent proteolysis as well as the 
many other ubiquitin-dependent cellular processes.  
 
 
MATERIALS AND METHODS 
Yeast strain construction 
To create the wild-type strain used in all experiments, a deletion of the UBA1 gene 
was generated by a gene disruption technique described previously (Guthrie and Fink; 
1991).  UBA1 was replaced by Kanmx, which was amplified by PCR using oligos  
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NG34 
(5'AAAAAGTAAGATTAGTAGCAAAGCAAAGAACATATAACTATAGCTTCGACGTACGC
TGCAGGTCGAC-3') and  
NG37 
(5'GGTTATAACGCATAGTGAACAAATGATGAGGTCTTGTAACTCGATTGCCATCGATG
AATTCGAGCTCG-3').  Transformation of the resulting PCR product into W303 cells and 
selection for kanamycin resistance resulted in RJD3267, which contained a deletion of the 
entire coding sequence (as well as a partial deletion of the Ste6 gene, causing sterility in 
mating type a cells).  The UBA1 gene was amplified from wild-type W303 S. cerevisiae 
cells by PCR using oligos  
NG19 (5'-CCGCTCGAGGGTAAAGTGGTTGAGCGAGGTA-3') and  
NG20 (5'-GGACTAGTGAATTGCCATTACGCTTCC-3'; XhoI and SpeI sites 
underlined).  The resulting PCR product, which contained UBA1 coding sequences plus 
186 bp upstream of the start codon and 269 bp downstream of the stop codon, was cloned 
into the CEN plasmid pRS316 to generate plasmid pRS316-UBA1.  The diploid yeast 
strain RJD3267 was transformed with the pRS316-UBA1 plasmid, sporulation was 
induced, and a haploid strain was selected that contained both the deletion of UBA1 and 
pRS316-UBA1 marked by URA3.  A plasmid shuffling strategy was used to replace 
pRS316-UBA1 with pRS313-UBA1.  The resulting strain, RJD3268, was used as the wild-
type control strain in this study.  
To generate mutant alleles of UBA1, random mutations were introduced into the 
UBA1 gene by error-prone PCR using the GeneMorph Random Mutagenesis Kit 
(Stratagene, La Jolla, CA), NG19 and NG20 primers, and pRS316-UBA1 as the template.  
A gapped plasmid was created by digesting pRS313 with NheI.  RJD3268 was 
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cotransformed with the mutagenized PCR product and the gapped pRS313 plasmid and 
transformants were plated onto –His media.  Cells that had lost the URA plasmid carrying 
wild-type UBA1 were selected by replica plating onto plates containing 5-fluoro-orotic acid 
incubated at 25°C.  Fifty temperature-sensitive mutants were identified by screening for 
colonies that grew at 25 but not at 37°C.  
 
Viability and stress sensitivity assay 
Wild-type and uba1-204 yeast cells were grown to an optical density of A600 = 1.  
Ten-fold serial dilutions were spotted onto YPD plates and SD plates containing 30 µM 
CdCl2.  All plates were incubated at the indicated temperatures for 2-3 days.   
 
Flow cytometric analysis of DNA content 
Cells were grown to log phase in YPD, washed, then incubated with 50 ng/ml α-
factor for 2 hours at 25°C to arrest cells in G1 phase.  For the experiment in Figure 1C, an 
additional 25 ng/ml α-factor was added and cultures were incubated at 37°C for 1hour.  
Cells were washed with YPD to reverse the α-factor arrest and resuspended in fresh YPD 
medium at 37°C.  For the experiment in Figure 1D, an additional 25 ng/ml α-factor was 
added and cells were kept at 25°C for 1 hour.  Cells were washed and grown in YPD at 
25°C for 90 minutes to allow progression to G2 phase before shifting the cultures to 37°C.   
Samples were withdrawn at indicated times after the shift to nonpermissive 
temperature, centrifuged at 13K rpm and resuspended in 70% ethanol for 1 hour at 4°C.  
The cell suspension was centrifuged for 5 minutes and washed with 50 mM sodium citrate.  
Cells were resuspended in 50 mM sodium citrate containing 0.25 mg/ml RNAse A and 
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incubated at 50°C for 1 hour.  Cells were centrifuged and washed with phosphate-
buffered saline pH 7.2.  Proteinase K was added to 2 mg/ml and cells were incubated at 
50°C for an additional hour.  Propidium iodide was added at a final concentration of 16 
µg/ml.  Immediately prior to flow cytometric analysis, cells were sonicated twice at setting 3 
for 3 seconds, and filtered with Tekto mesh screen into Falcon 2058 polystyrene tubes.   
 
Extract preparation 
Cells were harvested by centrifugation and frozen in liquid nitrogen.  Cells were 
then resuspended in buffer containing 50 mM Tris (pH 7.5), 10% glycerol, 0.1% β-
mercapto-ethanol, and 1% SDS.  An equal volume of glass beads (Sigma, 425-600 µg, 
acid washed) was added and cell pellets were boiled for 3 minutes, vortexed in a 
ThermoSavant FastPrep for 45 seconds at a speed of 5.5, and boiled for an additional 2 
minutes.  Samples were resolved by SDS-PAGE, transferred to nitrocellulose, and probed 
with the indicated antibody. Antibodies were kindly provided by K. Madura (Robert Wood 
Johnson Medical School-UMDNY, Piscataway, NJ) for Rad23, M. Funakoshi (Kyushu 
University, Fukuoka, Japan) for Dsk2, R. Vierstra (University of Wisconsin-Madison, 
Madison, WI) for Rpn10, and J. Monaco (University of Cincinnati College of Medicine, 
Cincinnati, OH) for LMP..  Ubiquitin was detected with monoclonal antibody from 
Chemicon (Temecula, CA). 
 
Deg1-GFP degradation 
Cells harboring the Deg1-GFP plasmid (gift of R. Hampton) were grown in YP 
dextrose medium.  Cultures of exponentially growing haploid yeast cells were incubated at 
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25°C or shifted to the nonpermissive temperature 37°C for one hour, and cycloheximide 
was added to 0.5 mg/ml.  5 ml aliquots were harvested every fifteen minutes and extracts 
were prepared as above and analyzed with antiserum to GFP (Clontech, Mountain View, 
CA).  Strains used were RJD3272 (WT) and RJD3275 (uba1-204).   
 
UbV76-V-βgal degradation 
Cells harboring the GAL-UbV76-V-βgal plasmid (gift of A. Varshavsky) were grown 
in SC raffinose medium lacking uracil.  UbV76-V-βgal expression was induced at the 
permissive temperature for 1 hour by the addition of galactose to 2%.  Cultures were then 
incubated at either 25°C or shifted to 37°C for 1 hour and transferred to fresh medium 
containing 2% dextrose to extinguish synthesis of UbV76-V-βgal.  Portions were withdrawn 
every 15 minutes and processed for immunoblotting with antiserum to β-galactosidase. 
Strains used were RJD3271 (WT) and RJD3274 (uba1-204). 
 
Sic1 degradation 
Cells grown in SC raffinose medium lacking uracil were arrested with α-factor (50 
ng/ml) for 1 hour, and GAL-SIC1 expression was induced transiently for 1 hour by the 
addition of galactose to 2%.  Supplemental α-factor was added to 25 ng/ml when cells 
were shifted to 37°C for 1 hour.  Cells were then washed and transferred to fresh medium 
containing 2% dextrose to quench SIC1 expression, and portions were withdrawn every 30 
minutes and processed for immunoblotting with antiserum to Sic1 (gift of L. Johnston, 
National Institute for Medical Research, London, United Kingdom).  Strains used were 
RJD3270 (WT) and RJD3273 (uba1-204). 
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Native gel activity assay 
26S proteasome samples were purified as described below and resolved by 
nondenaturing PAGE as described in Glickman et al. 1998.  The gel was incubated with 
fluorogenic peptide Suc-LLVY-AMC for 10 minutes at 30 °C.  Proteolytic activity of the 
resolved complexes was visualized by exposure to UV light.  Protein complexes in the 
same gel were also detected with Coomassie blue stain.  
 
In vitro Ub-Sic1 degradation 
Ub-Sic1 was synthesized as described in Saeki et al. 2005.  0.5 µM Ub-Sic1 was 
incubated with 1 µM 26S proteasome in the presence of 3 mM Magnesium acetate and 1X 
ARS (Verma et al. 1997) for 0 or 5 minutes as specified.  Proteasomes treated with 100 
µM epoxomicin were pre-incubated with drug at 30°C for 30 minutes prior to addition of 
Ub-Sic1.  Reactions were terminated by adding SDS Laemmli buffer and samples were 
resolved by SDS-PAGE, blotted to nitrocellulose, and visualized with antibody to Sic1 (gift 
of L. Johnston).  
 
Preparation of extracts for affinity purification of 26S proteasomes 
Yeast strains RJD3276 (WT) and RJD3277 (uba1-204) were grown to log phase at 
25°C in medium containing 0.67% yeast nitrogen base minus amino acids, 2% dextrose, 
0.5% casamino acids, and 20 mg/l adenine and tryptophan.  Cultures were split in half and 
25°C cultures were incubated for 40 minutes at 25°C, while 37°C cultures were pelleted by 
centrifugation, resuspended in fresh 37°C medium, and incubated at 37°C for 40 minutes.  
Cells were pelleted by centrifugation for 5 minutes at 4°C for 25°C samples and at 37°C for 
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37°C samples.  Pellets were washed with 25°C or 37°C sterile water and frozen in liquid 
nitrogen for a minimum of 2 hours.  Frozen cell pellets were ground to a fine powder under 
liquid nitrogen in a mortar placed on a bed of dry ice.  Powder was resuspended in one 
pellet-volume of column buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 10% 
glycerol, 5 mM MgCl2, 5 mM ATP.  ATP Regenerating System (ARS) (Verma et al. 1997) 
was added and the lysates were clarified by centrifugation at 17,000 rpm for 20 minutes.  
Lysates were supplemented again with 5 mM ATP and 5 mM MgCl2 and incubated 
at 4°C for 2 hours with FLAG antibody-coupled beads from Sigma (St. Louis, MO) that had 
been pre-washed in 0.1 M glycine, pH3.5 and resuspended as a 50% slurry with column 
buffer.  For each sample, 1.5 ml of lysate was incubated with 1 ml bead slurry.  Bead-
bound proteins were pelleted and washed three times with high salt wash buffer consisting 
of the column buffer described above supplemented with 0.2% Triton X-100 and NaCl to a 
final concentration of 200 mM. 
For Coomassie blue staining, immunoprecipitations, and native gel experiments, 
bead-bound proteins were then washed twice with low-salt wash buffer containing 50 mM 
Tris-HCl, pH7.5, 20 mM MgCl2, 2 mM ATP.  All supernatant was aspirated with a 25 gauge 
needle, and the pellet was resuspended in three times its volume of elution buffer 
containing 25 mM Tris, pH7.5, 150 mM NaCl, 5 mM MgCl2, 2 mM ATP, and 100 µg/ml 
Flag peptide and proteins were eluted at 4°C for 3 hours.  Samples were analyzed by 
SDS-PAGE on a 4%-12% Tris-Glycine gel (Invitrogen, Carlsbad, CA).  
For proteasome binding experiments in Figure 6A-C, bead-bound proteasome 
complexes were resuspended in column buffer and incubated with 1 mM phenanthroline, 
2.5 µM ubiquitin-aldehyde (Boston Biochem., Cambridge, MA), 100 µM MG132, 1 mM 
ATP, and 5 mM MgCl2 on ice for 1 hour.  Purified proteins were added as indicated and 
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samples were incubated on ice for 1 hour.  GST-Rad23, GST-UbL, GST-UBA, and 
Rad23-HIS were gifts from R. Verma (Caltech), Sic1 was a gift from G. Kleiger (Caltech), 
and Ub4 was from Boston Biochem. (Cambridge, MA).  The bound fraction was washed 
three times with high salt wash buffer, twice with low salt wash buffer, supernatant was 
aspirated, and proteins were eluted with SDS loading buffer and analyzed by SDS-PAGE 
on a gradient gel.   
 
MG132 binding assay 
Yeast strains that were sensitive to proteasome inhibitors were generated by 
deletion of the pdr5 gene.  RJD3983 (WT) and RJD3984 (uba1-204) were grown in 
casamino acids medium at 25°C and MG132 (American Peptide, Sunnyvale, CA) or 
DMSO was added.  After five minutes 37°C medium was added to shift cells to the 
nonpermissive temperature and cultures were incubated at 37°C for 1 hour.  Cells were 
centrifuged at 37°C for five minutes and flash frozen.  26S proteasome complexes were 
purified as described above.   
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C h a p t e r  4  
QUANTITATIVE MASS SPECTROMETRIC ANALYSIS OF 
AFFINITY PURIFIED 26S PROTEASOME COMPLEXES 
 
INTRODUCTION 
Ubiquitin-dependent proteolysis is the major non-lysosomal pathway of protein 
degradation in eukaryotic cells.  While regulation of the enzymatic cascade responsible for 
polyubiquitination of proteins has been thoroughly studied, the mechanisms involved in 
recognition and delivery of ubiquitinated substrates to the proteasome remain unclear.  
Recent work has shown that a diverse set of ubiquitin-binding receptors function to control 
the targeting of ubiquitinated proteins to the proteasome in a substrate-specific manner 
(Chen and Madura 2002; Elsasser et al. 2004; Verma et al. 2004; Wilkinson et al. 2001; 
reviewed in Elsasser and Finley 2005; Hicke et al. 2005).  
Recent developments in mass spectrometry technology have enabled proteomic 
analysis of ubiquitinated proteins and their interaction with the proteasome (reviewed in Xu 
and Peng 2006).  Large-scale analysis of His6-ubiquitinated peptides by mass 
spectrometry uncovered 1075 putative ubiquitinated proteins (Peng et al. 2003).  Work 
done in our laboratory coupled the one-step affinity purification of intact proteasome 
complexes with mass spectrometry to create a new approach to analyzing the 
“interactome” of the proteasome (Verma et al. 2004).  The success of these large-scale 
proteomic analyses lead to further investigation of the ubiquitin-proteasome pathway using 
genetic mutants to profile specific ubiquitination pathways.  Hitchcock et al. (2003) used 
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this approach to identify a set of membrane-associated substrates of the endoplasmic 
reticulum associated degradation (ERAD) pathway and Mayor et al. (2005) identified 
ubiquitinated proteins that are selectively accumulated in rpn10Δ cells.   
Multidimensional Protein Identification Technology (MudPIT) is a recent strategy 
that uses “shotgun proteomics” (Wolters et al. 2001), separating proteins that have been 
digested into peptides rather than intact proteins.  This allows analysis of complex protein 
mixtures by capillary chromatographic separation of peptides.  Once the peptide mixture is 
loaded onto the column, the column is placed in-line with an electrospray-ionization ion-
trap tandem mass spectrometer (Link et al. 1999; Washburn et al. 2002; Wolters et al. 
2001).  Acquired fragmentation spectra are matched to translated genomic sequence data 
via Sequest (Eng et al. 1994).  MudPIT has been successfully used in our laboratory to 
study the S. cerevisiae ubiquitin-proteasome system (Verma et al. 2004; Mayor et al. 
2005, Graumann et al. 2004), and its implementation is discussed in detail in the 
dissertation of Johannes Graumann (2006). 
Our recent characterization of a genetic mutant strain in which ubiquitin remains 
inactive, inert, and unable to label proteins for degradation by the proteasome provides a 
unique cellular environment for mass spectrometric analysis.  We have demonstrated that 
in uba1-204 cells, proteasome complexes remain intact and active, but do not encounter 
ubiquitinated substrates (Ghaboosi and Deshaies 2007).  In addition, these proteasomes 
associate with lower levels of the ubiquitin-binding proteins Rad23 and Dsk2.  In this study, 
we analyze proteasome complexes isolated from wild-type and uba1-204 mutant cells 
using MudPIT in order to determine the affect of cellular depletion of ubiquitin chains on 
the association of proteins with the proteasome.  This work was done in collaboration with 
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Johannes Graumann, Thibault Mayor, and Geoff Smith, who conducted LC/MS/MS 
analysis of peptide samples which I prepared.  While this is a preliminary study and the 
findings described here have yet to be validated, this work does highlight the potential 
value of this novel ubiquitin pathway mutant in systematic analysis of the ubiquitin-
proteasome pathway. 
 
 
RESULTS 
MudPIT analysis of metabolically labeled proteasome complexes 
Having established a unique cellular environment in which proteasome complexes 
were presented with severely reduced levels of ubiquitinated substrates and ubiquitin-
binding proteins Rad23 and Dsk2, we next tested the feasibility of using MudPIT to 
determine the proteomic affect on the proteasome complex.  In order to create protein 
populations in vivo that are distinguishable by mass spectrometry, cell cultures were grown 
in conditions that would create metabolically labeled proteins (Oda et al. 1999; MacCoss et 
al. 2003).  Wild-type and uba1-204 cells were grown in minimal media supplemented with 
a “heavy” 15N nitrogen source or a “light” 14N nitrogen source, respectively, in the form of 
ammonium acetate.  Thus, proteins formed in each strain were uniformly labeled with 
peptides displaying a discernible mass shift.   The technique of metabolic labeling also 
allows preparation and analysis of samples to be done simultaneously rather than in 
parallel.  Wild-type and uba1-204 cells are mixed, lysed, separated in the same column, 
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and analyzed simultaneously, reducing any potential discrepancies due to errors in 
experimental reproducibility. 
First, strains were generated which could be grown in minimal media.  Wild-type 
(RJD3983) and uba1-204 (RJD3984) strains were grown in different growth conditions in 
order to label proteins from each strain with “heavy” or “light” nutrients. Cultures were 
shifted to the nonpermissive temperature for twenty minutes, and proteasome complexes 
were affinity purified as described in materials and methods.  Affinity purified proteins from 
wild-type and uba1-204 cells were mixed and digested.  The peptide mixture was 
delivered to Johannes Graumann who, in conjunction with Thibault Mayor and Geoff 
Smith, analyzed the samples by multidimensional LC-MS/MS, or MudPIT.  The spectra 
generated were evaluated using algorithms from Sequest (Eng et al. 1994) and 
DTASelect/Contrast (Tabb et al. 2002) and quantification software RelEx (MacCoss et al. 
2003) was used to generate comparative results. 
By coupling the affinity purification of intact proteasome complexes with 
quantitative mass spectrometry, we were able to identify a total of 383 proteins, including 
all subunits of the proteasome.  Comparative quantitation of labeled peptides yielded 234 
proteins that had unaltered levels in mutant cells, 60 proteins that were depleted in 
proteasomes isolated from uba1-204 cells, and 89 proteins that were enriched in the uba1-
204 proteasome sample (Figure 4-1). 
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Figure 4-1.  Distribution of ratio of 14N-labeled peptides from uba1-204 cells / 
15N-labeled peptides from wild-type cells. 
Proteasome-associated proteins with unaltered levels in uba1-204 
Of the proteins that were quantified at similar levels in wild-type and mutant cells, 
all subunits of the proteasome were observed (Figure 4-2).  This result was confirmed 
experimentally by resolving affinity purified proteasome complexes by SDS-PAGE and 
visualizing subunits by Coomassie blue staining (Figure 3-4A).   
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Figure 4-2. List of proteins with unaltered abundance in uba1-204 proteasomes. 
List of identified proteins for which quantitative analysis showed unaltered 
peptide levels in uba1-204 and wild-type samples.  “204/WT” reflects the ratio of 
14N/15N isotope-labeled peptides, “SD” lists the standard deviation, and 
“peptides” is the number of peptides identified for each protein.   
 
Unfortunately, although Rad23 has been identified in previous mass spectrometry 
experiments, we were unable to determine the presence of either Rad23 or Dsk2 in our 
proteomic analysis.  This is likely due to the low levels of these substoichiometric proteins 
present at the proteasome.  However, we did recover some proteins that are known to be 
involved in the ubiquitin-proteasome pathway, including Cdc48, which was identified by 7 
peptides at quantitative levels that were unaltered in the mutant.  Indeed, we had 
  
74 
experimentally observed that, unlike Rad23 and Dsk2, the amount of Cdc48 associated 
with the proteasome was not affected in uba1-204 cells (Figure 4-3).    
 
Figure 4-3.  Cdc48 association with the proteasome is unaffected in uba1-204 
cells.  Wild-type and uba1-204 cells expressing Pre1-FH were grown in 
casamino acid medium and half the cultures were shifted to 37°C for 40 minutes.  
Lysates were prepared and immunoprecipitated as described in materials and 
methods by incubation with anti-Flag resin in the presence of ATP.  Intact 26S 
proteasomes were eluted with Flag peptide, separated by SDS-PAGE, and 
proteasome-bound proteins were detected by immunoblotting with antiserum to 
the specified proteins. 
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Proteasome-associated proteins with depleted levels in uba1-204 
Due to the large amount of information obtained from a single MudPIT experiment, 
we focused our attention on the relatively small number of proteins that displayed altered 
association with proteasomes purified from uba1-204 cells.  Proteins which are more 
abundant at the proteasome, including stoichiometric components such as subunits, will 
be represented by more identified peptides.  While multiple peptide hits increases the 
confidence in the abundance calculation, proteins that have been identified by a single 
peptide may also yield important results.  To uncover proteins that would be present at 
extremely low levels, such as ubiquitinated substrates, proteins identified by a single 
peptide were included.  In multiple tandem mass spectrometric analyses of the soluble 
portion of the S. cerevisiae proteome, it was found that even proteins identified by single 
peptide hits generally resulted in accurate relative abundance calculations (Washburn et 
al. 2002).  Comparing our results to several other large-scale proteomic studies of 
ubiquitinated proteins confers an additional level of confidence to the data.  However, 
results obtained from this study, especially those based upon quantitation of a single 
peptide, should be verified by multiple mass spectrometric analyses or by biochemical 
means.     
Having established that these proteasome complexes bind to significantly lower 
levels of ubiquitin chains (Figure 3-5A) and that substrates are not degraded by these 
proteasomes in vivo (Figure 3-3), we anticipated a decrease in the levels of known 
ubiquitin-proteasome pathway substrates in the labeled peptides purified from mutant 
proteasomes.  Half of the proteins identified in this study as having the greatest decrease 
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in peptide levels in the mutant sample (and therefore a low 204/WT ratio) have also 
been identified as ubiquitinated proteins in multiple other screens (Peng et al. 2003; 
Hitchcock et al. 2003; Mayor et al. 2005; Verma et al. 2004) (Figure 4-4, right column). 
 
 
 
  
77 
 
 
  
78 
 
 
Figure 4-4.  List of proteins depleted in uba1-204 proteasomes.  List of genes 
identified as depleted in uba1-204 affinity purified 26S proteasome sample 
compared to wild-type sample.  “204/WT” reflects the ratio of 14N/15N isotope-
labeled peptides, “SD” lists the standard deviation, and “peptides” is the number 
  
79 
of peptides identified for each protein.  The column entitled “Ub” denotes proteins 
which have been identified in the following published mass spectrometry 
experiments:  (a) Peng et al. 2003; (b) Hitchcock et al. 2003; (c) Mayor et al. 
2005; (d) Verma et al. 2004.  
In addition to the identification of proteins shown to be ubiquitinated in previous 
mass spectrometric analyses, we also identified proteins that had been experimentally 
proven to be substrates of the ubiquitin-proteasome pathway.  Sec23, a component of the 
COPII coat vesicle essential for transport between the endoplasmic reticulum and Golgi, 
was identified by multiple peptides at levels that were significantly decreased in the uba1-
204 sample, suggesting that it may be a ubiquitinated substrate of the proteasome (Figure 
4-4).  Indeed, it has been shown that formation of the COPII complex is regulated by the 
ubiquitination and degradation of Sec23 (Cohen et al. 2003).  Interestingly, all subunits of 
the COPII complex and its regulators were identified in this screen, including Sec24, 
Sec13, Sec31 (Figure 4-5).  In addition, its regulators Sar1, and Arf1 and the 
deubiquitination complex Bre5 and Ubp3 were also identified (Figure 4-2, 4-4). 
 
  
80 
Proteasome-associated proteins with enhanced levels in uba1-204 
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Figure 4-5.  List of proteins enriched in uba1-204 proteasomes.  Genes 
identified as enriched in uba1-204 affinity purified 26S proteasome sample 
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compared to wild-type sample.  “204/WT” reflects the ratio of 14N/15N isotope-labeled 
peptides, “SD” lists the standard deviation, and “peptides” is the number of 
peptides identified for each protein.  The column entitled “Ub” denotes proteins 
which have been identified in the following published mass spectrometry 
experiments:  a) Peng et al. 2003; b) Hitchcock et al. 2003; c) Mayor et al. 2005; 
d) Verma et al. 2004.  Asterisk denotes proteins shown to be ubiquitinated in 
other studies.  The ubiquitination of Taf5 is described in Auty et al. (2004) and 
ubiquitination of Rvs167 is described in Stamenova et al. (2004). 
In an attempt to validate the result showing increased levels of Cic1 at uba1-204 
proteasomes, we obtained Cic1 antibody from the laboratory of Dr. Dieter Wolf.  
Unfortunately, our results were inconclusive using the crude anti-Cic1 serum provided.  
However, considering this protein’s role as an adaptor protein, recruiting Cdc4 and Grr1 for 
degradation by the proteasome (Jager et al. 2001), our study highlights the importance of 
further analysis of the possible regulation of the interaction of this protein with the 
proteasome.  
 
 
DISCUSSION 
In this study, we describe the first application of MudPIT to the examination of 
proteasome complexes isolated in the absence of ubiquitin chains.  Although experimental 
validation of the findings described here is beyond the scope of this study, we have 
provided a useful survey of the spectrum of proteins that are targeted to the proteasome.  
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These data confirmed that intact proteasome complexes can be purified from uba1-204 
cells and that all subunits of the proteasome are present with little variation on their 
abundance.  Furthermore, it is possible to gain some valuable insights into the future 
potential of proteomic analysis of uba1-204 cells by comparing our results to previously 
published works.  
We had anticipated identifying potential novel substrates of the ubiquitin-
proteasome pathway in the proteins that were depleted in the mutant sample.  Indeed, one 
of the most depleted proteins, the Sec23 component of COPII coat of vesicles, was 
identified by three peptides and is known to be polyubiquitinated and degraded by the 
proteasome (Cohen et al. 2003).  Intriguingly, we also encountered all proteins involved in 
the formation of the coat protein complex (COPII), which produces transport vesicles to 
mediate export of proteins from the endoplasmic reticulum.  Transport vesicle formation 
begins when the GTPase Sar1 associates with the ER membrane and recruits a protein 
complex, which includes Sec23, Sec24, Sec13, and Sec31.  Sec23 is regulated by 
ubiquitination, which disrupts its interaction with Sec24 because of a direct effect of 
ubiquitination on protein conformation or association of the monoubiquitinated Sec23 with 
ubiquitination machinery, such as the proteasome (Cohen et al. 2003). Cohen et al. have 
shown that Ubp3-Bre5 complex is required to cleave the first conjugated ubiquitin from 
Sec23, resulting in accumulation of monoubiquitinated Sec23.  This facilitates subsequent 
polyubiquitination and degradation by the proteasome.  Thus, the balance between 
polyubiquitination of Sec23 and its deubiquitination and rescue from degradation by Ubp3-
Bre5 controls Sec23 levels in order to regulate cell growth and viability (Cohen et al. 2003).  
The decrease in Sec23 protein observed at uba1-204 proteasomes further 
establishes its role as a ubiquitin pathway substrate and provides a validation of the 
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strategy described here to identify substrates by analyzing peptides depleted in 
proteasome complexes isolated in uba1-204 cells.  In addition, our identification of the 
entire COPII complex lends support to the hypothesis described in Cohen et al. that the 
proteasome may associate directly with ubiquitinated Sec23 at the site of the COPII 
vesicle formation.  Interestingly, all three proteins that combine with Sec23 to form the 
COPII vesicle, Sec13, Sec31, and Sec24, are enriched at proteasomes in the absence of 
polyubiquitin.   
While we had expected to observe ubiquitinated proteasome substrate proteins 
depleted in uba-204 cells, it was less clear what types of proteins would be enriched in the 
mutant proteasomes.  We reasoned that with very few normal substrates being targeted to 
the proteasome, it would be possible to identify a unique set of proteasome-interacting 
proteins.  This may include adaptor proteins, ubiquitin-independent substrates, proteins 
with lower affinity for the proteasome, or monoubiquitinated proteins.  By focusing on a few 
proteins identified in the results, it is possible to gain an idea of the proteomic environment 
in proteasomes in uba1-204.   
Cic1 was isolated in our screen as the protein most enriched in proteasomes 
isolated in the absence of Uba1 activity.  Cic1 interacts in vitro and in vivo with the 
proteasome and with Cdc4 and thought to act as an adaptor protein, recruiting F-box 
proteins Cdc4 and Grr1 for degradation (Jager et al. 2001).  Cic1 mutants stabilize Cdc4 
and Grr1, substrate recognition subunits of the SCF complex (Jager et al. 2001).  If this 
protein indeed functions as an adaptor mediating the degradation of specific, important 
ubiquitin-proteasome pathway substrates, its increased presence in proteasomes isolated 
from uba1-204 cells suggests that its docking onto the proteasome is regulated. 
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Mex67 is an mRNA nuclear export receptor that contains a UBA domain that is 
required for proper mRNA export (Gwizdek et al. 2006).  Mex67 interacts with ubiquitin 
chains and with Hpr1, a protein that couples transcription to mRNA export.  The interaction 
with Mex67 is required to protect Hpr1 from ubiquitination and degradation (Gwizdek et al. 
2006).  Rvs167, a protein involved in receptor internalization and organization of the actin 
cytoskeleton, was shown to be ubiquitinated in earlier mass spectrometry studies (Peng et 
al. 2003; Hitchcock et al. 2003) and found to be enriched in this study.  Recently, it was 
verified that monoubiquitination of Rvs167 by the Rsp5 ligase regulates a protein complex 
required for endocytosis (Stamenova et al. 2004).   
In summary, our findings provide additional support to earlier mass spectrometric 
studies that sought to identify new candidate substrates of the ubiquitin-proteasome 
system.    Furthermore, we have found examples of the merit of using uba1-204 in 
analyzing ubiquitin’s many other activities beyond proteolysis, such as vesicle trafficking, 
mRNA export, and endocytosis.  While the large amount of information provided in this 
study provides more questions than answers, it highlights the value of this novel genetic 
mutant in uncovering new cellular roles for ubiquitin.  By enabling broad shutdown of all 
cellular ubiquitination in a matter of minutes, we can delve into the countless cellular 
processes that require this truly ubiquitous protein.   
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MATERIALS AND METHODS 
Preparation of extracts for affinity purification of 26S proteasomes 
Yeast strains were grown to log phase at 25°C in medium containing 0.67% yeast 
nitrogen base minus amino acids, 2% dextrose, 0.5% ammonium sulfate.  Cultures were 
diluted to OD600 = 0.008, with wild-type culture media containing 15N ammonium sulfate and 
uba1-204 media containing 14N ammonium sulfate.  This allows wild-type cells to grow for 
at least 7 generations in order to label all proteins with the “heavy” nitrogen.  At OD600 = 1, 
cultures were filtered and resuspended in media which was prewarmed to 37°C.  Cultures 
were incubated at 37°C for 20 minutes and pelleted by centrifugation for 5 minutes at 
37°C.  Pellets were washed with sterile water and flash frozen in liquid nitrogen. 
Frozen cell pellets were ground to a fine powder under liquid nitrogen in a mortar 
placed on a bed of dry ice.  Powder was resuspended in one pellet-volume of column 
buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM MgCl2, 5 mM 
ATP.  ATP Regenerating System (ARS) (Verma et al. 1997) was added and the lysates 
were clarified by centrifugation at 17,000 rpm for 20 minutes.  
Lysates were supplemented again with 5 mM ATP and 5 mM MgCl2 and incubated 
at 4°C for 2 hours with FLAG antibody-coupled beads from Sigma (St. Louis, MO) that had 
been prewashed in 0.1 M glycine, pH3.5 and resuspended as a 50% slurry with column 
buffer.  For each sample, 1.5 ml of lysate was incubated with 1 ml bead slurry.  Bead-
bound proteins were pelleted and washed three times with high salt wash buffer consisting 
of the column buffer described above supplemented with 0.2% Triton X-100 and NaCl to a 
final concentration of 200 mM.  Bead-bound proteins were then washed twice with low-salt 
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wash buffer containing 50 mM Tris-HCl, pH7.5, 20 mM MgCl2, 2 mM ATP.  All 
supernatant was aspirated with a 25 gauge needle and the pellet was resuspended in 
three times its volume of elution buffer containing 25 mM Tris, pH7.5, 150 mM NaCl, 5 mM 
MgCl2, 2 mM ATP, and 100 µg/ml Flag peptide and proteins were eluted at 4°C for 3 
hours.  
 
Mass Spectrometry and Data Analysis 
To generate peptides for mass spectrometry, proteasome samples were incubated 
with 3 mM Tris-(2-carboxyethyl)phosphine (T-CEP) for 20 minutes and then for another 15 
minutes following addition of iodoacetamide to 11 mM.  0.3 g Endoproteinase Lys-C 
(Boehringer Mannheim) was added and the sample was then digested for 6 hours at 37°C.  
Samples were diluted with buffer (100 mM Tris-HCl, pH 8.0, 1.33 mM CaCl2) and 
incubated with 1 µg of trypsin (Roche Applied Science) overnight at 37°C.  
Samples were processed for multidimensional chromatography as described in 
Graumann et al. (2004).  MS/MS spectra recorded by Xcaliber (ThermoElectron) were 
analyzed for charge state and controlled for data quality by 2to3 (Sadygov et al. 2002).  
Results were searched against translated open reading frames of the Saccharomyces 
Genome Database (SGD) (Cherry et al. 1998).  The spectra generated were evaluated 
using algorithms from Sequest (Eng et al. 1994) and DTASelect/Contrast (Tabb et al. 
2002) and quantification software RelEx (MacCoss et al. 2003) was used to generate 
comparative results.  
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C h a p t e r  5   
FINDINGS AND IMPLICATIONS 
One of the major contributions of this thesis is the creation and characterization of 
the first strong loss-of-function conditional allele of Saccharomyces cerevisiae UBA1 gene.  
Uba1-204 provides a new method for genetically inhibiting the ubiquitin-proteasome 
pathway in yeast.  The most striking result was the loss of all detectable ubiquitin 
conjugates within five minutes of incubation at the nonpermissive temperature.  This 
suggests an unprecedented mechanism for shutdown of ubiquitin-dependent cellular 
functions.  Furthermore, this conditional phenotype is reversible with similarly fast kinetics.  
This renders it necessary to maintain mutant cells at the nonpermissive temperature; 
however, it simultaneously increases the usefulness of this mutant in future experiments. 
In characterizing this allele, we have demonstrated strong stabilization of a range of 
substrate proteins.  However, considering that at least one protein, Clb2, has been shown 
to be unaffected, it remains to be seen how broad these protein stabilization effects are.  
Certainly this mutant strain will prove valuable in determining the ubiquitin dependence or 
ubiquitin independence of pathway substrates and could help to identify new substrates or 
even new ubiquitin-dependent processes.   It may also provide hints to better 
understanding the structure-function relationships of E1 and E1-like proteins.  
Furthermore, we have employed the cellular loss of ubiquitin chains to address an 
unanswered question regarding the proteasomal targeting of ubiquitinated substrates.  
Rad23 is known to recognize ubiquitin chains via its UBA domain and to bind to the 
proteasome via its UbL domain.  However, it was previously unknown which process 
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occurred first.  By investigating the affect of ubiquitin-chain depletion on Rad23 targeting 
function, we were able to provide clues to the mechanistic details involved in this process.  
Our results reveal that Rad23 engages with ubiquitin chains prior to its association with the 
proteasome, providing evidence to support the “shuttle factor” model of substrate 
targeting.  It would have been difficult to distinguish between the two proposed models 
without a method of inhibiting ubiquitination.  Another aspect of our findings was that in 
addition to ubiquitinated substrate, free ubiquitin chains are also sufficient to trigger Rad23 
shuttling.  If free ubiquitin chains can exploit Rad23 binding activity in vivo, our data 
suggest that they could compete with ubiquitinated substrates for proteasome targeting as 
well.   
The finding that ubiquitin chains are required for efficient targeting of ubiquitin-
binding receptors to the proteasome further demonstrated that proteasome complexes 
isolated from uba1-204 cells contained a unique “interactome” of proteins.  To explore the 
global effects of this ubiquitin pathway block, we examined the proteomic profile of 
proteins that copurified with proteasome complexes in the presence and absence of Uba1 
activity using MudPIT.  This initial proteomic analysis of proteasomes isolated from mutant 
cells hints at the potential of this method in identifying novel substrates, adaptors, and 
regulators of the proteasome.  
Overall, this thesis provides characterization of a valuable new genetic tool for 
inhibiting the ubiquitin-proteasome pathway.  This research makes a significant 
contribution towards elucidating the molecular mechanisms involved in regulating the 
targeting of ubiquitinated proteins to the proteasome.  It is my hope that this work will 
contribute to further exploration of the many roles that ubiquitin plays in proteolysis, as well 
as in other ubiquitin-dependent cellular processes. 
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APPENDIX I:  STRAIN LIST AND PLASMID MAP 
STRAIN LIST 
Note:  Mat a strains are sterile due to a partial deletion of the overlapping STE6 gene. 
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PLASMID MAP OF PRS313-UBA1 
Map of pRS313-UBA1.  The UBA1 gene was cloned into the linker region of the 
Saccharomyces/E. coli CEN vector pRS313 to generate RDB1837.  The gene includes the 
endogenous promoter and terminator regions to drive expression, including 186 base pairs 
upstream of the start codon and 269 base pairs downstream of the stop codon.   
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